risperidone has been researched along with quetiapine fumarate in 685 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 30 (4.38) | 18.2507 |
| 2000's | 346 (50.51) | 29.6817 |
| 2010's | 247 (36.06) | 24.3611 |
| 2020's | 62 (9.05) | 2.80 |
| Authors | Studies |
|---|---|
| Skarsfeldt, T | 1 |
| Stip, E | 1 |
| Bakshi, V; Geyer, MA; Swerdlow, NR | 1 |
| Borsini, F; Cerutti, M; Fodritto, F; Monferini, E; Volonté, M | 1 |
| Davidson, M; Levy, A; Weizer, M | 1 |
| Wirshing, WC | 1 |
| Lemon, MD | 1 |
| Sharif, ZA | 1 |
| Harris, MJ; Jeste, DV; Lacro, J; Lohr, JB; Rockwell, E | 1 |
| Abraham, D; Kissling, W; Leucht, S; Pitschel-Walz, G | 1 |
| Malone, RP; Sheikh, R; Zito, JM | 1 |
| Citrome, L; Volavka, J | 2 |
| Purdon, SE | 1 |
| Kane, JM | 2 |
| Kapur, S; Remington, G | 3 |
| Stahl, SM | 2 |
| Chatterjee, A; Dunayevich, E | 1 |
| Maneeton, N; Srisurapanont, M | 1 |
| Baker, GB; Chue, PS; Prior, TI; Tibbo, P | 1 |
| Healy, E; Pipe, R; Subotsky, F | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Ahlenius, S; Oerther, S | 1 |
| Liddle, P; Lussier, I; Mendrek, A; Ngan, E; Stip, E | 1 |
| Awad, AG; Voruganti, LN | 1 |
| Schulz, SC | 1 |
| Keck, PE; McElroy, SL; Strakowski, SM | 1 |
| Glazer, WM | 1 |
| Jeste, DV | 2 |
| Masand, PS | 1 |
| Zarate, CA | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| Kaplan, M | 1 |
| Baldessarini, RJ; Tarazi, FI; Zhang, K | 4 |
| McAskill, R; Taylor, DM | 1 |
| Lore, C | 1 |
| Kahn, RS | 1 |
| Bebbington, P; Freemantle, N; Geddes, J; Harrison, P | 1 |
| Ghaemi, SN | 1 |
| Charney, DS; Sernyak, MJ; Stolar, M; Woods, SW | 1 |
| Hilger, E; Kasper, S | 1 |
| Chue, P; Snaterse, M; Welch, R | 1 |
| Lieberman, JA | 1 |
| Phan, NB; Still, DJ; True, J; Valibhai, F | 1 |
| Beelen, AP; Lewis, LD; Yeo, KT | 1 |
| Howard, HR; Lebel, LA; Schmidt, AW; Zorn, SH | 1 |
| Revicki, DA | 1 |
| Brown, WA; Khan, A; Khan, SR; Leventhal, RM | 1 |
| Arnold, LM; Keck, PE; McElroy, SL | 1 |
| Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR | 1 |
| Griffiths, J; Springuel, P | 1 |
| Bauzon, D; Bymaster, FP; Cohen, ML; DeLapp, NW; Falcone, JF; Kennedy, JS; Schenck, K | 1 |
| Buckley, PF | 1 |
| Weizman, A; Weizman, R | 1 |
| Jibson, MD; Mullen, J; Sweitzer, D | 1 |
| Kuroki, T; Tashiro, N | 1 |
| Boonyanaruthee, V; Chan-Ob, T; Kuntawongse, N | 1 |
| Philibin, SD; Porter, JH; Vann, RE; Varvel, SA; Wise, LE | 1 |
| McIntyre, RS | 1 |
| Alva, G; Arvanitis, LA; Bera, R; Potkin, SG; Thyrum, PT; Yeh, C | 1 |
| Alarcon, RD; Leslie, DL; Losonczy, MF; Rosenheck, R; Sernyak, MJ | 1 |
| Boulton, DW; DeVane, CL; Liston, HL; Markowitz, JS | 1 |
| Weissman, EM | 1 |
| Bronisch, T; Brunner, J; Wetter, TC | 1 |
| Bai, O; Bowen, R; Keegan, D; Li, XM; Lu, W; Wei, Z | 1 |
| Quartermain, D; Rosengarten, H | 1 |
| Jessen, LM | 1 |
| Awad, A; Cernovsky, Z; Cortese, L; Kotteda, V; Owyeumi, L; Voruganti, L; Zirul, S | 1 |
| Fernandez, HH; Friedman, JH | 1 |
| Bullock, R; Saharan, A | 1 |
| Ballon, JS; Boyd, JA; Marder, SR; Meng, LR; Wirshing, DA; Wirshing, WC | 1 |
| Berk, M; Malhi, GS | 1 |
| Cunningham, F; Hamed, A; Huang, YH; Kazis, LE; Lee, AF; Miller, DR; Ren, XS | 1 |
| Goudie, AJ; Smith, JA | 1 |
| Barbui, C; Danese, A; Guaiana, G; Mapelli, L; Miele, L; Monzani, E; Percudani, M | 1 |
| Keller, R; Mongini, F | 1 |
| Mullen, JA; Sajatovic, M; Sweitzer, DE | 1 |
| Danileviciūte, V | 1 |
| Kunwar, AR; Megna, JL | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Gupta, S | 1 |
| Castle, DJ; Lambert, TJ | 1 |
| Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B | 1 |
| Bailey, RK | 1 |
| Bobes, J; Fernández, I; Garcia-Garcia, M; García-Portilla, MP; Hernández, G; Rejas, J; Rico-Villademoros, F | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Edell, WS; Rupnow, MF | 1 |
| Lacy, TJ; Motsinger, CD; Perron, GA | 1 |
| Woods, SW | 1 |
| Baldessarini, RJ; Kula, NS; Tarazi, FI; Zhang, K | 1 |
| Nishikawa, T; Takeuchi, T | 1 |
| Koyama, T; Nakagawa, S | 1 |
| Ali, JA; Ali, LJ; Desai, KD | 1 |
| Bozikas, VP; Deseri, C; Karavatos, A; Pitsavas, S | 1 |
| Azzoni, A; Raja, M | 2 |
| Higuchi, H; Kamata, M; Naitoh, S; Shimizu, T; Sugita, T; Takahashi, H; Yoshida, K | 1 |
| Hedges, D; Jeppson, K; Whitehead, P | 1 |
| Fric, M; Laux, G | 1 |
| Lieberman, JA; Stroup, TS | 1 |
| Blow, FC; Copeland, LA; Valenstein, M; Zeber, JE | 1 |
| Conley, RR; Kelly, DL; Kreyenbuhl, J; Love, RC; Van-Duong, Q | 1 |
| Tamminga, CA | 2 |
| Czimmer, C; Janka, Z; Juhász, A; Kéri, S; Rimanóczy, A; Szekeres, G; Szendi, I | 1 |
| Kabanov, SO; Mosolov, SN | 1 |
| Bous, H; Bruggeman, R; Castelein, S; Kluiter, H; Knegtering, R; van den Bosch, RJ; Van Der Linde, J | 1 |
| Anziano, R; Cutler, NR; Harrigan, EP; Miceli, JJ; Middle, M; Reeves, KR; Shiovitz, T; Sramek, J; Watsky, E | 1 |
| Bahk, WM; Kim, JJ; Lee, C; Lee, CU; Lee, KU; Lee, SJ; Pae, CU; Paik, IH | 1 |
| Cohen, D | 1 |
| Mandrioli, R; Pucci, V; Raggi, MA; Sabbioni, C | 1 |
| Buckley, PF; Glazer, W; Sebastian, CS | 1 |
| Berardi, D; De Ronchi, D; Lorenzi, C; Serretti, A | 1 |
| Cheng, Z; Li, H; Li, K; Li, X; Peng, W; Wang, F; Xie, Z; Zhou, Z; Zhu, R | 1 |
| Bitter, I | 1 |
| Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M | 1 |
| Advokat, C; Comaty, JE; Dixon, D; Schneider, J | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F | 1 |
| Bitter, I; Boland, J; Dossenbach, M; el Mahfoud Kessaci, M; Erol, A; Hodge, A; O'Halloran, RA; Shaheen, MO; Sunbol, MM | 1 |
| Findling, RL; McNamara, NK | 1 |
| Bressan, RA; Jones, HM; Pilowsky, LS | 1 |
| Anil, AE; Ertugrul, A; Jayathilake, K; Meltzer, HY; Roy, A; Sumiyoshi, T | 1 |
| Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T | 1 |
| Assion, HJ; Schwenkreis, P | 1 |
| Joyce, AT; Ollendorf, DA; Rucker, M | 1 |
| Budin, R; Davidson, P; Fleming, AS; Kapur, S; Li, M | 1 |
| Cramer, JA; Sernyak, M | 1 |
| Ismail, MS; Profenno, LA; Tariot, PN | 1 |
| Baskys, A | 1 |
| Ballard, CG; Margallo-Lana, ML | 1 |
| Barbee, JG; Conrad, EJ; Jamhour, NJ | 1 |
| Agid, O; Houle, S; Hussain, T; Kapur, S; Remington, G; Tauscher, J; Verhoeff, NP; Wilson, AA; Zipursky, RB | 1 |
| Leslie, DL; Rosenheck, RA | 1 |
| Allingham, B; Citrome, L; Jaffe, A; Levine, J; Robinson, J | 1 |
| Curtis, LH; Dans, PE; Hutchison, S; Krishnan, RR; Masselink, LE; Schulman, KA; Wright, A; Østbye, T | 1 |
| Mintzer, JE; Mullen, JA; Sweitzer, DE | 1 |
| Adler, LE; Bowles, A; Cawthra, EM; Freedman, R; Hall, MH; Harris, JG; McRae, KA; Nagamoto, HT; Olincy, A; Ross, RG; Waldo, MC; Woodward, L | 1 |
| Cancro, R; Chuang, L; Jacobson, J; Lusskin, SI | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Shayegan, DK; Stahl, SM | 1 |
| Lara, DR; Souza, DO; Tort, AB | 1 |
| Finkel, S | 1 |
| Katz, IR | 1 |
| Mori, K; Morinobu, S; Nagao, M; Okamoto, Y; Yamashita, H; Yamawaki, S | 2 |
| Köhnlein, O; Lutz, R; Messer, T; Schmauss, M | 1 |
| Byerly, M; Carmody, T; Holland, R; Li, B; Miller, DR; Montgomery, JH; Varghese, F | 1 |
| Haeno, M; Kaminiwa, S; Kohara, K; Kuroki, T; Ninomiya, H | 1 |
| Barna, I; Gazdag, G; Iványi, Z; Tolna, J | 1 |
| Conley, RR; Kelly, DL | 2 |
| Adams, MA; du Toit, RM; Heaton, JP; Millson, RC | 1 |
| Edgell, ET; Haro, JM; Kennedy, L; Lambert, M; Naber, D; Novick, D; Ratcliffe, M | 1 |
| Degen, K; Grogg, AL; Irish, WD; Lopez, RB; Mladsi, DM; Nimsch, CT; Swann, A | 1 |
| Grootens, KP; Verkes, RJ | 1 |
| Conley, RR; Kelly, DL; Lambert, TJ; Love, RC | 1 |
| Malik, AR; Ravasia, S; Wolf, PK | 1 |
| Keck, PE | 1 |
| Curtis, V | 1 |
| Meltzer, HY | 2 |
| Meltzer, HY; Purdon, SE; Woodward, ND; Zald, DH | 1 |
| Carson, W; Chang, KY; Chou, CH; Lambert, BL; Tafesse, E | 1 |
| Allison, DB; Casey, DE; Cope, MB; Fernández, JR; Geary, N; Nagy, TR | 1 |
| Dubois, D | 1 |
| Gianfrancesco, F; Pesa, J; Wang, RH | 1 |
| Cohen, LJ; Galynker, I; Grebchenko, Y; Khan, A; Malaya, L; Ten, A; Yanowitch, P | 1 |
| Kuehn, BM | 1 |
| Leslie, DL; Miller, EA; Rosenheck, RA | 1 |
| Ascher-Svanum, H; Correll, C; Faries, D; Kane, J; Zhu, B | 1 |
| Goikolea, JM; Vieta, E | 1 |
| Cho, SC; Chungh, DS; Kim, BN | 1 |
| Matsui-Sakata, A; Ohtani, H; Sawada, Y | 1 |
| Jansson, E; Melkersson, K | 1 |
| Herrmann, N; Mamdani, M; Rapoport, M; Rochon, PA; Shulman, KI | 1 |
| Raskind, MA; Rosin, RA | 1 |
| Bitter, I; Czobor, P; Dossenbach, M; Volavka, J | 1 |
| Aguilar, J; Arango-Dávila, C; Assunção, S; Caro, O; Dossenbach, M; Landa, E; Leadbetter, J; Silva Ibarra, H | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Brown, D; Fraser, K; Martin, M; Taylor, M; Turner, M; Watt, L | 1 |
| Harris, S; Layton, D; Shakir, SA; Wilton, LV | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Altman, C; de Nayer, A; Jones, AM; Larmo, I; Lindenbauer, B; Platz, T; Rittmannsberger, H; Windhager, E | 1 |
| Hsiao, MC; Lin, YH; Liu, CY | 1 |
| Baser, O; Engelhart, L; Finkel, S; Greenspan, A; Kozma, C; Long, S; Mahmoud, R | 1 |
| Danielyan, A; Kowatch, RA | 1 |
| Balit, CR; Isbister, GK; Kilham, HA | 1 |
| Gharabawi, G; Greenspan, A; Kwentus, J | 1 |
| Dehning, S; Douhet, A; Engel, RR; Möller, HJ; Müller, N; Musil, R; Riedel, M; Schwarz, MJ; Spellmann, I; Strassnig, M | 1 |
| Delisi, LE; Nasrallah, HA | 1 |
| Clifton, PG; Hartfield, AW; Moore, NA | 1 |
| Byerly, MJ; Fisher, R; Magouirk, B; Nakonezny, PA; Rush, AJ | 1 |
| Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R | 1 |
| Adams, DH; Kinon, BJ; Liu-Seifert, H | 1 |
| Baker, AJ; Kymissis, PI; Stevens, JR | 1 |
| Luchins, DJ | 1 |
| Hsiao, JK; Lieberman, JA | 1 |
| Banks, SM; Pandiani, JA | 1 |
| Calabrese, JR; Elhaj, O; Gajwani, P; Gao, K | 1 |
| Covell, NH; Essock, SM; Jackson, CT | 1 |
| Carnahan, RM; Chrischilles, EA; Lund, BC; Perry, PJ | 1 |
| Ballard, C; Waite, J | 1 |
| Davis, J; Heres, S; Jetzinger, E; Kissling, W; Leucht, S; Maino, K | 1 |
| Adler, AI; Dibben, CR; Dinneen, SF; Hynes, FA; Kalavalapalli, SS; Linnington, HE; McKenna, PJ | 1 |
| Bitter, I; Jones, RM; Thompson, C | 1 |
| Birkás Kováts, D; Cseh, K; Faludi, G; Palik, E | 1 |
| Abdous, B; Cooper, D; Gaudet, M; Grégoire, JP; Moisan, J | 1 |
| Bai, O; Li, XM; Xu, H | 1 |
| Akram, A; Anders, M; Araszkiewicz, A; Dossenbach, M; Dyachkova, Y; Khalil, A; McBride, M; Pecenak, J; Pirildar, S; Shakhnovich, T; Treuer, T | 1 |
| Birinyi-Strachan, L; Davey, P; Kongsakon, R; Leelahanaj, T; Price, N | 1 |
| Kostulski, A; Rabe-Jabłońska, J; Wyszogrodzka-Kucharska, A | 1 |
| Balshaw, R; Kopala, L; Love, L; Malla, A; Smith, G; Talling, D; Williams, R | 1 |
| Gianfrancesco, FD; Rajagopalan, K; Sajatovic, M; Wang, RH | 2 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Bloch, MH; Bracken, MB; Coric, V; Kelmendi, B; Landeros-Weisenberger, A; Leckman, JF | 1 |
| Boettger, S; Breitbart, W | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Masand, P; Nassir Ghaemi, S; Pae, CU; Patkar, A | 1 |
| Friedman, AB; Li, X; Rosborough, KM; Roth, KA; Zhu, W | 1 |
| Doraiswamy, PM; Levine, JG; Szarfman, A; Tonning, JM | 1 |
| Bettcher, BM; Byerly, MJ; Carmody, T; Fisher, R; Nakonezny, PA; Rush, AJ | 1 |
| Antoniello, N; Falvo, F; Ferrari, E; Govoni, S; Mansi, V; Rondanelli, M; Sarra, S; Solerte, SB | 1 |
| Rustembegovic, A; Sofic, E; Wichart, I | 1 |
| Staller, J | 1 |
| Rasmussen, K | 1 |
| Bossie, CA; Burtea, V; Davidson, M; Gharabawi, GM; Greenspan, AJ; Kosik-Gonzalez, C; Mahmoud, R; Potkin, SG; Rupnow, MF; Trivedi, JK; Zhu, Y | 1 |
| DeVane, CL; Donovan, JL; Markowitz, JS; Wang, JS; Zhu, HJ | 1 |
| Gorobets, LN | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Wheeler, A | 1 |
| Marlowe, K; Schirgel, D | 1 |
| Ehret, MJ; Levin, GM | 1 |
| Hamer, RM; Lieberman, JA; Sweitzer, DE; Zhong, KX | 1 |
| Bies, RR; Chew, ML; Gharabawi, G; Greenspan, A; Kapur, S; Kirshner, MA; Lehman, ME; Mulsant, BH; Pollock, BG | 1 |
| Cunningham, FE; Dalack, GW; Hur, K; Lambert, BL; Miller, DR | 1 |
| Atagun, I; Kaya, MC; Kurt, E; Oral, ET; Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
| Dagerman, KS; Davis, SM; Hsiao, JK; Ismail, MS; Lebowitz, BD; Lieberman, JA; Lyketsos, CG; Ryan, JM; Schneider, LS; Stroup, TS; Sultzer, DL; Tariot, PN; Weintraub, D | 1 |
| Awad, AG; Bossie, CA; Gharabawi, GM; Greenspan, A; Kalali, AH; Kosik-Gonzalez, C; Rupnow, MF; Zhu, Y | 1 |
| Brecher, M; Harvey, PD; Patterson, TL; Potter, LS; Zhong, K | 1 |
| Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D | 1 |
| Adams, DH; Citrome, L; Kinon, BJ; Liu-Seifert, H | 1 |
| Covell, NH; Davis, SM; Essock, SM; Lieberman, JA; Rosenheck, RA; Stroup, TS | 1 |
| De Oliveira, IR; Juruena, MF | 1 |
| Allison, DB; Cope, MB; Jumbo-Lucioni, P; Kesterson, RA; Nagy, TR; Walton, RG | 1 |
| Asai, K; Shimada, Y; Tanaka, Y; Ueda, H; Yoshida, S | 1 |
| Belz, I; Capuano, GA; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Capuano, G; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; McGee, MF; Perkins, DO; Reimherr, F; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Dierks, T; Irisawa, S; Isotani, T; Kikuchi, M; Kinoshita, T; Koenig, T; Okugawa, G; Strik, W; Yagyu, T; Yamada, K; Yoshimura, M | 1 |
| Freeman, MP; Gelenberg, AJ | 1 |
| Bossie, CA; Gharabawi, GM; Greenspan, AJ; Kujawa, MJ; Pandina, GJ; Zhu, Y | 1 |
| Kudo, T | 1 |
| Gianfrancesco, F; Goldberg, JF; Rajagopalan, K; Wang, RH | 1 |
| Farver, D | 1 |
| Fong, SY; Lam, MH; Wing, YK | 1 |
| Haushofer, M; Pfolz, H; Rainer, M; Struhal, C; Wick, W | 1 |
| Förstl, H | 1 |
| Amitai, N; Markou, A; Semenova, S | 1 |
| Post, DE | 1 |
| Carlsson, A; Stening, G; Timdahl, K | 1 |
| Hui, HY; Law, WL; You, JH; Young, WM | 1 |
| Bilder, RM; Capuano, G; Davis, CE; Davis, SM; Gold, JM; Green, MF; Harvey, PD; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Palmer, BW; Perkins, DO; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Fisher, JE; Yury, CA | 1 |
| Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA | 1 |
| Harrison, BE; Therrien, B | 1 |
| Ashton, J; Garcia-Quiroga, J; Harrison-Woolrych, M; Herbison, P | 1 |
| Gu, H; Hamer, RM; Lazarus, A; Lieberman, JA; McEvoy, JP; Olexy, C; Perkins, DO; Strakowski, SD; Sweitzer, D; Weiden, P | 1 |
| Gu, H; Hamer, RM; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Sweeney, JA | 1 |
| Dehning, S; Douhet, A; Engel, RR; Kleindienst, N; Möller, HJ; Müller, N; Opgen-Rhein, M; Riedel, M; Spellmann, I; Strassnig, M; Valdevit, R | 1 |
| Carlson, GA; Findling, RL; Flanders, SC; Jensik, SE; Pandina, GJ; Rupnow, MF; Youngstrom, EA | 1 |
| Agid, O; Arenovich, T; Kapur, S; Remington, G; Zipursky, RB | 1 |
| Daiello, LA | 1 |
| Vandenberg, AM; Wright, TM | 1 |
| Gordon, ML; Kohen, I; Manu, P | 1 |
| Beach, AJ; Calamaras, MR; DeVane, CL; Donovan, J; Gibson, BB; Knight, BT; Nemeroff, CB; Newport, DJ; Owens, MJ; Stowe, ZN; Viguera, AC; Winn, S | 1 |
| Binder, CE; Fallu, A; Yatham, LN | 1 |
| Akhtar, S; Ameen, S; Sahoo, S | 1 |
| Dimpfel, W | 1 |
| Den, R; Kashima, H; Manki, H; Nio, S; Nomura, K; Suzuki, T; Takeuchi, H; Tanabe, A; Tomita, M; Tsunoda, K; Uchida, H; Watanabe, K; Yagi, G | 1 |
| Wooten, J | 1 |
| Engelhart, LM; Gharabawi, GM; Harvey, PD; Hassman, H; Mahmoud, RA; Mao, L | 1 |
| Bogetto, F; Fonzo, V; Montemagni, C; Pandullo, P; Rocca, P; Villari, V | 1 |
| Gharabawi, GM; Greenspan, A; Kosik-Gonzalez, C; Rupnow, MF; Stahl, SM; Zhu, Y | 1 |
| Hassan, M; Islam, S; Kalsekar, ID; Kavookjian, J; Madhavan, SS; Makela, EH; Miller, LA; Rajagopalan, K | 1 |
| Parrinello, G; Sacchetti, E; Valsecchi, P | 1 |
| Allen, MH; Nordstrom, K | 1 |
| Bick, P; Castle, D; Knoesen, N | 1 |
| Kirchheiner, J; Mehler-Wex, C; Romanos, M; Schulze, UM | 1 |
| Barnett, MJ; Perry, PJ; Wehring, H | 1 |
| Keshavan, MS; Kupfer, DJ; Miewald, JM; Montrose, DM; Prasad, KM | 1 |
| Avorn, J; Brookhart, MA; Choudhry, NK; Mogun, H; Patrick, A; Schneeweiss, S; Setoguchi, S; Wang, PS | 1 |
| Alonso, J; Bousoño, M; Ciudad, A; Gilaberte, I; Haro, JM; Novick, D; Suárez, D | 1 |
| Perlis, RH | 1 |
| Cejpková, A; Rodáková, I; Svestka, J; Synek, O; Tomanová, J | 1 |
| Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P | 1 |
| Canive, JM; Davis, SM; Hsiao, JK; Khan, A; Lieberman, JA; McEvoy, JP; McGee, M; Miller, DD; Reimherr, F; Stroup, TS; Swanson, JW; Swartz, MS; Wagner, HR | 1 |
| Arkadiev, V; Diana, L; Lim, K; Rossvanes, C; Ruedrich, SL; Swales, TP | 1 |
| Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ | 1 |
| Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR | 1 |
| Czarnecki, K; Josephs, KA; Kumar, N | 1 |
| Aparasu, RR; Chen, H; Jano, E; Johnson, M | 1 |
| Byerly, MJ; Nakonezny, PA; Rush, AJ | 1 |
| Gu, H; Hamer, RM; Lieberman, JA; McEvoy, JP; Perkins, DO; Weiden, PJ | 1 |
| Lawrie, SM; Shajahan, P; Taylor, M | 1 |
| Corey-Lisle, PK; Crosby, RD; Kan, HJ; Kolotkin, RL; McQuade, RD | 1 |
| Ascher-Svanum, H; Correll, CU; Faries, DE; Kane, JM; Zhu, B | 1 |
| Agoston, T; István, S; Tamás, T; Zoltán, J | 1 |
| Cañas, F; Perez, V; Tafalla, M | 1 |
| Sutton, BJ | 1 |
| Allingham, B; Citrome, L; Jaffe, A; Levine, J; Martello, D | 1 |
| Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Galarraga, W; Gendron, A; Jacobs, L; Katzman, MA; Kong, B; Lessard, S; Marcus, M; Struzik, L; Vermani, M | 1 |
| Albrecht, C; Bliesener, N; Cooper-Mahkorn, D; Creutz, C; Cvetanovska, G; Hornung, WP; Klingmüller, D; Kühn, KU; Lemke, MR; Maier, W; Schubert, M; Sträter, B; Westheide, J | 1 |
| Washburn, CF | 1 |
| Fiedler, T; Gutmann, P; Wustmann, T | 1 |
| Dagerman, KS; Davis, SM; Hsiao, JK; Lebowitz, BD; Lieberman, JA; Lyketsos, CG; Rosenheck, RA; Schneider, LS; Sultzer, DL; Tariot, PN | 1 |
| Chang, KD | 1 |
| Findling, RL | 1 |
| Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Daumit, GL; Davis, SM; Davis, VG; Goff, DC; Hsiao, J; Lieberman, JA; McEvoy, JP; Meyer, JM; Nasrallah, HA; Stroup, TS; Swartz, MS | 1 |
| Kashima, H; Nakajima, S; Nomura, K; Suzuki, T; Takeuchi, H; Tanabe, A; Uchida, H; Watanabe, K; Yagi, G | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| Arango, C; Cifuentes, A; Fraguas, D; Giráldez, M; Laita, P; Merchán-Naranjo, J; Moreno, D; Parellada, M; Ruiz-Sancho, A | 1 |
| Aouizerate, B; Rotgé, JY; Tignol, J | 1 |
| Bahk, WM; Cho, HS; Chung, SK; Ha, K; Jon, DI; Kim, W; Lee, E; Min, KJ; Seo, JS; Shin, YC; Yoon, BH | 1 |
| Avila, M; Bae, S; Chen, LA; Djokovic, M; Kaiser, K; Nejtek, VA; Podawiltz, A; Rush, AJ; Zielinski, T | 1 |
| Bharadwaj, R; Grover, S | 1 |
| Ayache, L; Buysschaert, M; Fagnart, O; Feys, JL; Gruson, D; Hermans, MP; Jamart, J; Luts, A; Mertens de Wilmars, S; Misson, A; Oriot, P | 1 |
| Clement, HW; Heiser, P; Hemmeter, UM; Krieg, JC; Schmidt, AJ; Schulz, E; Vedder, H | 1 |
| Anjum, A; Jensen, JB; Kumra, S; Lee, SS; Leitten, W; Oberstar, J; Schulz, SC; White, T; Wozniak, J | 1 |
| Arango, C; Baeza, I; Castro-Fornieles, J; de la Serna, E; Gonzalez-Pinto, A; Graell, M; Moreno, D; Parellada, M; Paya, B; Soutullo, CA | 1 |
| Alvarez, M; Arango, C; de Castro, MJ; Fraguas, D; Giráldez, M; Laita, P; Leiva, M; Merchán-Naranjo, J; Moreno, D; Parellada, M; Pascual, D; Rapado, M | 1 |
| Marshall, TS; McCombs, JS; Stafkey-Mailey, D | 1 |
| Haug, HJ; Kolb, SA; Koponen, H; Lublin, H; Sigmundsson, T | 1 |
| Cretaz, E; Diniz, BS; Forlenza, OV | 1 |
| Anders, M; Dossenbach, M; Irimia, V; Kotler, M; Logozar-Perkovic, D; Lowry, AJ; Pecenak, J; Peciukaitiene, D; Smulevich, AB; Szulc, A; Treuer, T; West, TM | 1 |
| Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Hanssens, L; Kerselaers, W; L'Italien, G; Loze, JY; Marcus, RN; Pans, M | 1 |
| Silva, R | 1 |
| Ascher-Svanum, H; Ball, T; Conley, R; Liu, L; Stauffer, V | 1 |
| Brecher, M; Emsley, R; Eriksson, JW; Leong, RW; Leonova-Edlund, J; Meulien, D; Miller, F; Newcomer, JW; Ratner, RE | 1 |
| Dagerman, KS; Hsiao, JK; Lebowitz, BD; Lyketsos, CG; Mack, WJ; Schneider, LS; Stroup, TS; Sultzer, DL; Tariot, PN; Vigen, C; Zheng, L | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Charach, A; Gearing, RE | 1 |
| Peritogiannis, V; Tsouli, S | 1 |
| Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ | 1 |
| Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| Fukui, N; Ozdemir, V; Someya, T; Suzuki, Y; Watanabe, J | 1 |
| Duncan, EJ; Dunlop, BW; Hamer, RM; Woolson, SL | 1 |
| Heard, K; Hoppe, J; Tan, HH | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Albanese, MJ; Khantzian, EJ | 1 |
| Barbui, C; Boso, M; Cipriani, A | 1 |
| Chandrasena, R; Davis, L; Dickson, R; Hanley, J; Karagianis, J; Monga, N; Procyshyn, R; Thakur, A; Williams, R | 1 |
| Aberg, K; Adkins, DE; Lieberman, JA; McClay, JL; Perkins, DO; Stroup, S; Sullivan, PF; van den Oord, EJ; Vladimirov, VI | 1 |
| Haen, E; Hajak, G; Hausner, H; Wittmann, M | 1 |
| Gaszner, P | 1 |
| Black, VC; Bobier, CM; Buchan, JC; Craig, BJ; Pirwani, NZ; Swadi, HS | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Correll, CU; Kane, JM; Malhotra, AK; Manu, P; Napolitano, B; Olshanskiy, V | 1 |
| Assunção-Talbott, S; Carson, WH; Correll, CU; Goff, DC; Kane, JM; Kirkpatrick, B; Marder, SR; Pikalov, A; Sun, W; Vester-Blokland, E | 1 |
| Bond, DJ; Kauer-Sant'Anna, M; Lam, RW; Yatham, LN | 1 |
| Leckband, SG; Meyer, JM; Strack, DK | 1 |
| Cohen, D; Correll, CU; De Hert, M | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Srisurapanont, M | 1 |
| Conley, Y; Davies, MA; Roth, BL | 1 |
| Helm, ME; Henderson, C; Martin, BC; Pathak, P; West, D | 1 |
| Cellard, C; Lefèbvre, AA; Maziade, M; Roy, MA; Tremblay, S | 1 |
| Grégoire, JP; Moisan, J | 1 |
| Chatton, A; Claeys, F; Khan, R; Khazaal, Y; Ribordy, F; Zullino, D | 1 |
| Cheng, WR; Jenkins, TA; Reynolds, GP; Zhang, XR; Zhang, ZJ | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Mihaljević-Peles, A; Mihanović, M; Sagud, M; Silić, A; Zivković, M | 1 |
| Badr, MG; D'yachkova, Y; Dikeos, D; Fábián, Z; Harrison, G; Hudiţă, C; Okasha, T; Pesek, MB; Tapia-Paniagua, G; Treuer, T; Yang, F | 1 |
| Johnsen, E; Jørgensen, HA; Kroken, RA; Wentzel-Larsen, T | 1 |
| Friedman, JH | 1 |
| Alda, JA; Alvarez, M; Arango, C; Baeza, I; de la Serna, E; Giráldez, M; Martínez-Cantarero, C; Merchán-Naranjo, J; Moreno, C; Parellada, M; Sánchez, B | 1 |
| Bianchi, S; Chiabrando, G; Montanaro, N; Poluzzi, E; Scanavacca, P | 1 |
| Elsom, SJ; Gurvich, C; Kulkarni, J; McCauley-Elsom, K | 1 |
| Bosanac, P; Carty, B; Castle, D; Monshat, K; Olver, J | 1 |
| Dysken, MW; Lederle, FA; Rector, TS; Rossom, RC | 1 |
| Danilov, DS | 1 |
| Ciobica, A; Dobrin, I; Padurariu, M; Stefanescu, C | 1 |
| Bergmans, P; Cordes, J; de Arce, R; Eriksson, L; Gaebel, W; Rouillon, F; Schreiner, A; Smeraldi, E | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| Craig, TK; Elanjithara, T; Gafoor, R; Landau, S; McGuire, P; Power, P | 1 |
| Campbell, EC; Caroff, SN; Chakos, MH; Davis, SM; Davis, VG; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, DD; Riggio, S; Rosenheck, RA; Saltz, BL; Stroup, TS; Swartz, MS | 1 |
| Eng, ML; Welty, TE | 1 |
| Atallah, AN; Melnik, T; Puga, ME; Soares, BG | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Asenjo Lobos, C; Hunger, H; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Chen, J; Gao, K; Kemp, DE | 1 |
| Amminger, P; Berger, GE; Kerr, M; Kunstmann, C; Kunstmann, S; Lasch, J; Marculev, C; McGorry, PD; Milleit, B; Milleit, C; Nenadic, I; Proffitt, TM; Sauer, H; Smesny, S; Willhardt, I; Yotter, RA | 1 |
| Lee, SY; Pae, CU; Park, MH; Patkar, AA | 1 |
| Depping, AM; Kissling, W; Komossa, K; Leucht, S | 1 |
| Depping, AM; Gaudchau, A; Kissling, W; Komossa, K; Leucht, S | 1 |
| Depping, AM; Kissling, W; Komossa, K; Leucht, S; Meyer, M | 1 |
| Celikyurt, IK; Erden, FB; Kayir, H; Ulak, G; Ulusoy, GK; Uzbay, TI | 1 |
| Crouthamel, B; Sackett, G; Unis, A | 1 |
| Mandell, DJ; Sackett, GP; Unis, A | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Bobo, WV; Crystal, S; Gerhard, T; Huang, C; Lieberman, JA; Olfson, M | 1 |
| He, E; Li, M; Volf, N | 1 |
| Agid, O; Arenovich, T; Foussias, G; Kapur, S; Remington, G; Sajeev, G; Zipursky, RB | 1 |
| Cole-Strauss, A; Jandacek, R; Lipton, JW; McNamara, RK; Rider, T; Tso, P | 1 |
| Schmoll, D | 1 |
| Arango, C; Bretón, I; Camblor, M; Cuerda, C; de Castro, MJ; Desco, M; Dulín, E; García-Peris, P; Giráldez, M; Gutierrez, A; Leiva, M; Merchan-Naranjo, J; Parellada, M; Sanz, I; Velasco, C | 1 |
| Baker, RA; Forbes, RA; Guo, Z; Hebden, T; Jing, Y; Kim, E; L'italien, GJ | 1 |
| Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA | 1 |
| Chathanchirayil, SJ | 1 |
| Dagerman, KS; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lyketsos, CG; Mack, WJ; Sano, M; Schneider, LS; Stroup, TS; Sultzer, DL; Tariot, PN; Vigen, CL; Zheng, L | 1 |
| Ahearn, EP; Becker, T; Cordes, T; Juergens, T; Krahn, D | 1 |
| Ashton, J; Harrison-Woolrych, M; Herbison, P; Skegg, DC; Skegg, K | 1 |
| Hamer, RH; LaVange, LM; Lieberman, JA; McEvoy, JP; Nussbaum, AM; Perkins, DO; Ring, KD; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| de Arce Cordón, R; Eding, E; Marques-Teixeira, J; Milanova, V; Rancans, E; Schreiner, A | 1 |
| Abad-Santos, F; López-Rodríguez, R; Novalbos, J; Ochoa, D; Pelegrina, ML; Román, M | 1 |
| Faludi, G; Fejes, L; Inczédy-Farkas, G; Kassai-Farkas, A; Lazáry, J; Makkos, Z | 1 |
| Ariano, RE; Sokoro, AA; Zivot, J | 1 |
| Johnsen, E; Jørgensen, HA; Kjelby, E; Kroken, RA; Løberg, EM | 1 |
| Weiden, PJ | 1 |
| Carpiniello, B; Mellino, G; Pinna, F; Pintore, S; Puddu, L | 1 |
| Arndt, S; Chrischilles, EA; Coryell, WH; Ellingrod, VL; Fiedorowicz, JG; Haynes, WG; Miller, del D; Prabhakar, M; Warren, L | 1 |
| Diaz-Atienza, F; Gurpegui, M; Gutiérrez-Rojas, L; Jurado, D; Martínez-Ortega, JM | 1 |
| Dirican, E; Geyikoglu, F; Hacimuftuoglu, A; Keles, MS; Kirkpinar, I; Tatar, A; Togar, B; Turkez, H | 1 |
| Brunnauer, A; Laux, G | 1 |
| Iagubov, MI; Shtark, LN | 1 |
| Bond, DJ; Kozicky, JM; Lam, RW; Torres, IJ; Yatham, LN | 1 |
| Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM | 1 |
| Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I | 1 |
| Bschor, T; Erbe, S; Gutwinski, S | 1 |
| Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K | 1 |
| Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A | 1 |
| Berkowitz, RL; Docherty, JP; Ni, Q; Parks, JJ; Patel, U | 1 |
| Anderson, GM; Fischer, H; Gill, SS; Gruneir, A; Herrmann, N; Hyson, C; Marras, C; Rochon, PA; Wang, X | 1 |
| Chang, YT; Chen, CC; Chen, WJ; Kuo, CJ; Lee, WC; Liao, YT; Shau, WY; Tsai, SY; Yang, SY | 1 |
| Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML | 2 |
| Avorn, J; Crystal, S; Gerhard, T; Huybrechts, KF; Levin, R; Lucas, JA; Olfson, M; Schneeweiss, S | 1 |
| Jacobson, J; Munzig, E; Tavaré, CJ; Turkel, SB | 1 |
| Brown, WV; Cuthbert, B; Duncan, EJ; Hollis, JP; Kelly, DL; Koola, MM; Le, NA; Qualls, C; Raines, J | 1 |
| Knoepflmacher, D; Shapley, L; Turner, EH | 1 |
| Bhalerao, S; Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Seyfried, LS | 1 |
| Dunn, G; French, P; Hutton, P; Morrison, AP; Taylor, PJ; Yung, AR | 1 |
| Hermes, E; Rosenheck, R | 1 |
| Becker, T; Croissant, D; Eschweiler, GW; Frasch, K; Jaeger, S; Kilian, R; Längle, G; Messer, T; Pfiffner, C; Schepp, W; Steinert, T; Weiser, P | 1 |
| Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Abdallah, CG; Hong, X; Huang, H; Huang, Q; Jiang, L; Liang, C; Liu, Y; Wan, X; Wang, J; Wu, R; Xu, C; Zhang, J | 1 |
| Koek, RJ; Mintz, J; Yerevanian, BI | 1 |
| Ascher-Svanum, H; Bertsch, J; Brugnoli, R; Haro, JM; Hong, J; Novick, D | 1 |
| Moteshafi, H; Stip, E | 1 |
| Alvarez, E; Arranz, B; Corripio, I; Dueñas, R; Perez, V; Ramirez, N; Safont, G; San, L | 1 |
| Alexander, J; Bretag-Norris, R | 1 |
| Hetrick, SE; Loy, JH; Merry, SN; Stasiak, K | 2 |
| Li, H; Li, Y; Liu, Y; Qian, M; Yan, X; Yue, Y | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Anderson, GM; Fischer, HD; Herrmann, N; Marras, C; Rochon, PA; Wang, X | 1 |
| Arndt, S; Glorioso, DK; Golshan, S; Henry, R; Jeste, DV; Jin, H; Kraemer, HC; Mudaliar, S; Shih, PA | 1 |
| Gorman, D; Pringsheim, T | 1 |
| Correll, CU; De Hert, M; Kane, JM; Manu, P; Shiffeldrim, D; van Winkel, R; Wampers, M; Yu, W | 1 |
| Bourque, J; Champagne, J; Lakis, N; Lalonde, P; Lipp, O; Mendrek, A; Stip, E | 1 |
| Eade, A; Heilbronn, C; Lloyd, B; Lubman, DI; McElwee, P | 1 |
| Honaker, J; Lohr, WD | 1 |
| Brixner, DI; Ghate, SR; Hashibe, M; Joy, E; Porucznik, CA; Said, Q | 1 |
| Byerly, MJ; Glick, ID; Hamer, RM; Khan, AY; Lamberti, JS; McEvoy, JP; Nasrallah, HA; Ray, N; Steinbook, RM; Stroup, TS | 1 |
| Cheung, C; Chua, SE; Collier, DA; Deng, W; Gong, Q; Huang, C; Jiang, L; Li, M; Li, T; Ma, X; McAlonan, GM; Sham, PC; Wang, Q; Wang, Y | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Choi, NK; Jung, SY; Kwon, JS; Lee, J; Park, BJ; Shin, JY | 1 |
| Desjardins, O; Grégoire, JP; Moisan, J; Turgeon, M | 1 |
| Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Alessi-Severini, S; Biscontri, RG; Enns, MW; Metge, CJ; Vasilyeva, I | 1 |
| Stafford, N | 1 |
| Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T | 1 |
| Abad-Santos, F; Ayuso, C; Borobia, AM; Cabaleiro, T; Carcas, AJ; López-Rodríguez, R; Novalbos, J; Ochoa, D; Román, M | 1 |
| Bahk, WM; Wang, HR; Woo, YS | 1 |
| Goltz, M; Haro, JM; Krüger, H; Lambert, M; Naber, D; Peuskens, J; Schwarzmann, N | 1 |
| Amminger, GP; Becker, J; O'Donoghue, B; Papageorgiou, K; Schäfer, MR | 1 |
| Altamura, AC; Buoli, M; Serati, M | 1 |
| Choi, SH; Choi, WJ; Kim, JJ; Park, JY; Park, KM; Seok, JH; Yoon, HJ | 1 |
| Hugdahl, K; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM; Sinkeviciute, I | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Jiang, KD; Shen, XL; Wang, HF; Yang, XM; Zhang, HX; Zhou, H | 1 |
| Asmal, L; Flegar, SJ; Komossa, K; Leucht, S; Rummel-Kluge, C; Wang, J | 1 |
| Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J | 1 |
| Dore, J; Hill, SJ; Hooshmand, F; Ketter, TA; Miller, S; Portillo, N; Wang, PW | 1 |
| Lin, H; Rosenheck, R | 1 |
| Tsai, SJ; Wang, TY | 1 |
| Awad, G; Hassan, M; Hsu, J; Loebel, A; Pikalov, A; Rajagopalan, K | 1 |
| Blackburn, DF; Bresee, L; Champagne, A; Crawley, A; Lynds, S; Remillard, AJ; Tran, D | 1 |
| Chanoine, JP; Davidson, J; Devlin, AM; Lynn, FC; Ngai, YF; Nguyen, D; Panagiotopoulos, C; Sabatini, P | 1 |
| Bahramzi, M; Campillo, A; Minassian, A; Vilke, GM; Wilson, MP | 1 |
| Di Fiorino, M; Kasper, S; Montagnani, G; Trespi, G | 2 |
| Brawman-Mintzer, O; Gros, DF; Hershenberg, R | 1 |
| Hviid, A; Melbye, M; Pasternak, B; Ranthe, MF; Svanström, H | 1 |
| Hanft, A; Turkel, SB | 1 |
| Hu, JY; Huang, A; Liu, YY; Liu, ZL; Wang, LM; Wen, XJ | 1 |
| Kuntz, KM; Park, T | 1 |
| Morrissette, DA; Stahl, SM | 1 |
| Dixon, SN; Gandhi, S; Garg, AX; Hwang, YJ; Nash, DM; Pannu, N; Parikh, CR; Rehman, F; Reiss, JP; Shariff, SZ; Wald, R | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Andersen, CU; Dabrowski, K; Hansen, KB; Høimark, L; Sædder, E | 2 |
| Chiou, CC; Lane, HY; Lin, CY; Tsai, GE; Wang, HS; Wu, VY; Wu, YH | 1 |
| Baldycheva, I; Earley, W; Flach, AJ; Laties, AM; Pathak, S; Rak, I | 1 |
| Aiello, R; Citraro, R; De Sarro, G; Leo, A; Pugliese, M; Russo, E | 1 |
| Ghezai, H; Goldacre, B; Hodsoll, J; Miles, S; Smallcombe, N; Veale, D | 1 |
| Alda, JA; Arango, C; Baeza, I; Castro-Fornieles, J; Correll, CU; Cuerda, C; de Andrés, P; de la Serna, E; Fraguas, D; Giráldez, M; Martínez-Cantarero, C; Merchán-Naranjo, J; Moreno, C; Parellada, M | 1 |
| Brennan, MD; Ramsey, TL | 1 |
| Chang, YS; Lai, CY; Wu, YH | 1 |
| Crespo-Facorro, B; Prieto, C; Sainz, J | 1 |
| Damkier, P; Ennis, ZN | 1 |
| Goya, S; Kai, T; Kanemura, S; Kashiwagi, Y; Maeda, I; Matsuda, Y; Nakajima, S; Okamoto, Y; Taira, T; Takei, K; Tanimukai, H; Tokoro, A; Tokuyama, M; Tsujimoto, H; Tsujio, I; Watanabe, M | 1 |
| Caravaggio, F; Chung, JK; Fervaha, G; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mihashi, Y; Mulsant, B; Nakajima, S; Plitman, E; Remington, G; Takeuchi, H | 1 |
| Dixon, SN; Fraser, LA; Garg, AX; Hwang, YJ; Liu, K; Naylor, KL; Shariff, SZ | 1 |
| Berardi, MA; Caraceni, A; Caruso, R; Grassi, L; Mitchell, AJ; Nanni, MG; Riba, M | 1 |
| Chiang, HL; Hwang, TJ; Hwu, HG; Lin, YT; Shan, JC; Sheu, YH | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Chiang, C; Kales, H; Kim, HM; Schneider, LS; Weintraub, D | 1 |
| Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Maust, DT; Schneider, LS; Seyfried, LS | 1 |
| Brooks, KR; Kram, BL; Kram, SJ | 1 |
| Bozza, FA; do Brasil, PE; Ely, EW; Salluh, JI; Serafim, RB; Soares, M; Tura, BR | 1 |
| Baraniuk, A; Gavrilidis, E; Gilbert, H; Kulkarni, J; Storch, A; Worsley, R | 1 |
| DiPaula, BA; Feldman, S; Kelly, DL; Love, RC; McMahon, RP; Miller, J; Morris, AA; Raley, H; Wehring, H | 1 |
| Falter, T; Hefner, G; Hiemke, C; Shams, ME; Unterecker, S | 1 |
| Lin, H; McEvoy, J; Mohamed, S; Rosenheck, RA; Stroup, S; Swartz, M | 1 |
| Borodyuk, YN; Burdovitsina, TG; Kornetova, EG; Parshukova, DA; Semke, AV; Seregin, AA; Smirnova, LP; Tkacheva, GD | 1 |
| Ahmadi, M; Mojtahedi, D; Monajemi, MB; Moosavi, SM; Yazdani, J | 1 |
| Cucchiaro, J; Loebel, A; Mao, Y; Meyer, JM; Pikalov, A | 1 |
| Masi, G; Milone, A; Pisano, S; Stawinoga, A; Veltri, S | 1 |
| Ahonen, R; Hartikainen, S; Koponen, M; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM | 1 |
| He, L; Huang, H; Li, M; Minica, C; Qin, S; Shen, L; Shi, Y; Wang, G; Wu, X; Xing, Q; Xu, Q; Yi, Z | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Bulanov, VS; Gorobets, LN; Ivanova, GP; Litvinov, AV; Polyakovskaya, TP; Tsarenko, MA; Vasilenko, LM | 1 |
| Alda, JA; Andrés Nestares, P; Arango, C; Baeza, I; Cantarero, CM; Castro-Fornieles, J; de la Serna, E; Garcia-Amador, M; Merchán-Naranjo, J; Moreno, C; Muñoz, D; Tapia, C | 1 |
| Bahn, S; Guest, PC; Lago, SG; Leweke, FM; Rahmoune, H; Rothermundt, M; Schwarz, E; Steiner, J; Tomasik, J; van Beveren, NJM | 1 |
| Baytunca, MB; Erermis, S; Kose, S; Ozbaran, B | 1 |
| Koplewicz, HS | 1 |
| Auricchio, F; Baldelli, S; Bernardini, R; Bertella, S; Bravaccio, C; Capuano, A; Carnovale, C; Cattaneo, D; Clementi, E; Ferrajolo, C; Fucile, S; Guastella, G; Mani, E; Molteni, M; Pascotto, A; Pisano, S; Pozzi, M; Radice, S; Rafaniello, C; Riccio, MP; Rizzo, R; Rossi, F; Scuderi, MG; Sperandeo, S; Sportiello, L; Villa, L | 1 |
| Lee, SY; Lee, TL; Shyu, YC; Wang, LJ; Yang, CJ; Yang, KC; Yuan, SS | 1 |
| Davidson, J; Nguyen, D; Panagiotopoulos, C; Ronsley, R | 1 |
| Beillat, M; Robinson, P; Sapin, C; Tempest, M; Treur, M | 1 |
| Alda, JA; Andrés-Nestares, P; Arango, C; Baeza, I; Calvo-Escalona, R; Castro-Fornieles, J; Fernández-Avilés, F; Martínez-Cantarero, C; Merchán-Naranjo, J; Muñoz-Samons, D; Tapia-Casellas, C; Tor, J | 1 |
| Khouzam, HR | 1 |
| Amato, L; Indave, BI; Minozzi, S; Pani, PP | 1 |
| Bo, L; Saha, KB; Sampson, S; Xia, J; Zaman, RU; Zhao, S | 1 |
| Davis, JM; Furtado, VA; Hosalli, P; Sampson, S | 1 |
| Alessandra, A; Daniela, C; Elisa, M; Giuseppina, D; Maria, N; Paolo, C; Perna, G; Raffaele, B | 1 |
| Ake, T; Al-Dhaher, Z; Carbon, M; Correll, CU; David, L; Kane, JM; Kapoor, S; Krakower, S; Saito, E | 1 |
| Barbosa, DS; Bonifácio, KL; Brinholi, FF; Casagrande, R; Farias, CC; Higachi, L; Moreira, EG | 1 |
| Brobert, G; Heintjes, EM; Herings, RM; Overbeek, JA; Penning-van Beest, FJ | 1 |
| Ariyawansa, J; De Meulder, M; Remmerie, B; Savitz, A | 1 |
| De Meulder, M; Remmerie, B; Savitz, A; Weiner, S | 1 |
| Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S | 1 |
| Blais, L; Carrier, JD; Cohen, AA; Courteau, J; Delorme, A; Demers, MF; Fleury, MJ; Grignon, S; Larouche, A; Lesage, A; Roberge, P; Roy, MA; Vanasse, A | 1 |
| Brücher, B; Dechering, DG; Eckardt, L; Frommeyer, G; Köbe, J; Lange, PS; Mönnig, G; Pott, C; Reinke, F; von der Ahe, H; Wasmer, K | 1 |
| Cocker, KE; Reese, TR; Thiel, DJ | 1 |
| Alonso-Martín, C; Arias-Loste, MT; Crespo, J; Crespo-Facorro, B; Fábrega, E; Martínez-García, O; Morlán-Coarasa, MJ; Ortiz-García de la Foz, V; Romero-Gómez, M | 1 |
| Alphs, L; Correll, CU; Kim, E; Mao, L; Starr, HL | 1 |
| King, MB; Marston, L; Nazareth, I; Osborn, D; Petersen, I; Walters, K | 1 |
| Bervoets, C; Cleymans, S; Morrens, M | 1 |
| Loebel, A; Meyer, N; Rajagopalan, K; Wade, S | 1 |
| Ramcharran, D; Ryan, PB; Schuemie, MJ; Stang, PE | 1 |
| Ahonen, R; Hartikainen, S; Koponen, M; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM | 1 |
| Abe, T; Howard, R; Lebowitz, B; Mimura, M; Reeves, S; Roberts, R; Suzuki, T; Uchida, H; Yoshida, K | 1 |
| Barber, S; Cipriani, A; Corsi, M; Olotu, U | 1 |
| Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ | 1 |
| Arababadi, MK; Bahramabadi, R; Fathollahi, MS; Jafari, E; Samadi, M; Vakilian, A | 1 |
| Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Cuperfain, AB; Gonçalves, VF; Harripaul, R; Kennedy, JL; Maciukiewicz, M; Mittal, K; Müller, DJ; Rollins, B; Tiwari, AK; Vawter, MP; Zai, CC | 1 |
| Fujibayashi, M; Hattori, S; Hirayasu, Y; Ishii, C; Ishii, N; Kishida, I; Miyauchi, M; Moritani, T; Shiraishi, Y; Suda, A; Taguri, M; Tsujita, N | 2 |
| Baldelli, S; Bernardi, FF; Bernardini, R; Bravaccio, C; Capuano, A; Cattaneo, D; Cheli, S; Clementi, E; Molteni, M; Pozzi, M; Radice, S; Rafaniello, C; Rossi, F; Sessa, M | 1 |
| Mock, CK; Teslyar, P; Thom, RP | 1 |
| Castberg, I; Skogvoll, E; Spigset, O; Westin, AA | 1 |
| Alessi-Severini, S; Biscontri, RG; Bugden, S; Collins, DM; Jha, S; Katz, LY | 1 |
| Bartlett, MG; Callahan, PM; Hernandez, CM; Poddar, I; Terry, AV; Yang, X | 1 |
| Doblhammer, G; Eriksdotter, M; Garcia-Ptacek, S; Haenisch, B; Johnell, K; Nerius, M | 1 |
| Dietrich-Muszalska, A; Kolińska-Łukaszuk, J | 1 |
| Andreassen, OA; Dieset, I; Engum, A; Fjukstad, KK; Lydersen, S; Spigset, O; Steen, NE | 1 |
| Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T | 1 |
| Bramness, JG; Handal, M; Hartz, I; Hjellvik, V; Nesvåg, R; Skurtveit, S | 1 |
| Cepoiu-Martin, M; Chen, W; Cooke, L; Duncan, D; Pringsheim, T; Stang, A; Symonds, C | 1 |
| Hoti, F; Lähteenvuo, M; Taipale, H; Tanskanen, A; Tiihonen, J; Vattulainen, P; Vieta, E | 1 |
| Sakamoto, S; Sato, K; Takaki, M; Yamada, N; Yoshimura, B | 1 |
| Adams, CE; Ahmed, U; Hussein, M; Miramontes, K; Ostinelli, EG; Rehman, FU | 1 |
| Bateman, BT; Cohen, JM; Cohen, LS; Desai, RJ; Glynn, RJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Beckley, N; Hayes, J; Nazareth, I; Osborn, DP; Petersen, I; Walters, K | 1 |
| Bech, P; Correll, CU; Foldager, L; Mors, O; Østergaard, SD | 1 |
| Dias Alves, M; Micoulaud-Franchi, JA; Simon, N; Vion-Dury, J | 1 |
| Devlin, AM; Ngai, YF; Panagiotopoulos, C | 1 |
| Balcells, I; García-González, J; Honkanen, JK; Hovatta, I; Kieseppä, T; Lindgren, M; Mantere, O; Mäntylä, T; Raij, T; Saarnio, S; Suvisaari, J; Trontti, K; Vaarala, O | 1 |
| Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J | 1 |
| Deckert, J; Hommers, LG; Menke, A; Samanski, L; Scherf-Clavel, M; Unterecker, S | 1 |
| Bellavia, A; Centorrino, F; Fitzmaurice, G; Jackson, JW; Valeri, L | 1 |
| Deckert, J; Menke, A; Scherf-Clavel, M; Unterecker, S; Weidner, A | 1 |
| Furushima, D; Fushimi, K; Horiguchi, H; Iketani, R; Imai, S; Yamada, H | 1 |
| Cope, N; Fowler, JC; Knights, J; Makin, A; Peters-Strickland, T; Phiri, P; Rathod, S | 1 |
| Huang, A; Loebel, A; Messali, A; Ng-Mak, D; Wang, L | 1 |
| Bareis, N; Stroup, TS | 1 |
| Hartikainen, S; Koponen, M; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM | 1 |
| Bai, Y; Chen, G; Gao, K; Yang, H | 1 |
| Burk, BG; Nelson, LA | 1 |
| Bazo-Alvarez, JC; Carpenter, JR; Hayes, JF; Morris, TP; Petersen, I | 1 |
| Carson, RE; D'Souza, DC; Gaiser, E; Gallezot, JD; Henry, S; Huang, Y; Lin, SF; Matuskey, D; Nabulsi, N; Planeta, B; Radhakrishnan, R; Ropchan, J | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Juncal-Ruiz, M; Pelayo-Terán, JM; Romero-Jiménez, R; Setién Suero, E; Suárez-Pinilla, P; Vázquez-Bourgon, J | 1 |
| Liang, W; Lu, T; Su, Y; Yan, H; Yu, H; Yue, W; Zhang, D | 1 |
| Correll, CU; DiPetrillo, L; Jiang, Y; Liu, Y; Pathak, S; Todtenkopf, MS | 1 |
| Chen, Q; Coid, J; Deng, W; Guo, W; Hu, X; Li, K; Li, L; Li, T; Li, X; Li, Y; Lu, T; Lv, L; Ma, X; Ren, H; Reynolds, GP; Tan, L; Tan, Q; Tian, Y; Wang, C; Wang, H; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Chyou, TY; Nishtala, PS; Nishtala, R | 1 |
| Hong, SC; Jeong, JH; Kim, SM; Kim, TW; Oh, JH; Seo, HJ; Um, YH | 1 |
| Bîgiu, NF; Dima, L; Ifteni, P; Moga, MA; Popa, MA; Teodorescu, A | 1 |
| Escudero, MAG; Gutiérrez-Rojas, L; Lahera, G | 1 |
| Aguilar, V; Almenara, S; Ballester, P; Belda, C; Espadas, C; Londoño, AC; Peiró, AM; Pérez, E | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Gao, RL; Lim, KS; Luthra, AS | 1 |
| Kumazawa, R; Matsui, H; Sato, D; Uda, K; Yasunaga, H | 1 |
| Brambilla, P; Cantù, F; Ciappolino, V; Delvecchio, G; Enrico, P; Moltrasio, C | 1 |
| Andreassen, OA; Ingelman-Sundberg, M; Jukic, MM; Kyllesø, L; Molden, E; Smith, RL; Tveito, M | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
| Aronen, ET; Mogk, H; Rättö, H; Saastamoinen, LK; Varimo, E | 1 |
| Hashioka, S; Hayashida, M; Hotta, Y; Inagaki, M; Izuhara, M; Miura, S; Miyaoka, T; Nagahama, M; Otsuki, K; Shimizu, Y; Yamashita, S | 1 |
| Bernardo, M; García-Rizo, C; Gómez-Huelgas, R; Rico-Villademoros, F; Rojo, R | 1 |
| Liang, J; Shan, F; Zhang, YY; Zhou, XH | 1 |
| Alisauskiene, R; Gjestad, R; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM | 1 |
| Agarwal, SM; Asgariroozbehani, R; Bowden, S; Hahn, MK; McIntyre, WB; Remington, G; Siskind, D; Smith, E; Stogios, N; Tran, V | 1 |
| Baldessarini, RJ; Gaudiot, CES; Nestsiarovich, A; Tohen, M; Vieta, E; Zhu, Y | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
| Bell, JS; Hartikainen, S; Koponen, M; Lavikainen, P; Rajamaki, B; Taipale, H; Tanskanen, A; Tolppanen, AM | 1 |
| Bernardo, CO; Gonzalez-Chica, DA; Jureidini, J; Klau, J; Raven, M | 1 |
| Alomo, M; Arce, C; Chiapella, LC; Corral, RM; Cuesta, MJ; Farinola, R; Lopredo, LS; Prokopez, CR; Sfriso, LE; Vallejos, M | 1 |
| Abler, VC; Demos, GN; Mahadik, BS; Rajagopalan, K; Rashid, N; Yunusa, I | 1 |
| Correll, CU; Hagi, K; Kane, JM; Kishimoto, T; Kurokawa, S | 1 |
| Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A | 1 |
| Aakjær, M; Andersen, M; Baltzer Houlind, M; Brøgger Kristiansen, S; Lange, T; Sharon, R | 1 |
| Byeon, SJ; Chung, SJ; Oh, S | 1 |
| Osman, E; Yıldız, M | 1 |
| Chiappini, S; Giannantonio, MD; Martinotti, G; Miuli, A; Mosca, A; Pettorruso, M; Santovito, MC; Sensi, SL; Skryabin, V | 1 |
| Bartels-Velthuis, AA; Bruggeman, R; Burin, LM; Cahn, W; da Rocha, NS; de Haan, L; Hahn, MK; Schirmbeck, F; Simons, CJP; van Amelsvoort, T; van Os, J | 1 |
| Arango, C; Leucht, S; Lopez-Morinigo, JD | 1 |
| Chan, HY; Chen, JJ; Lin, CH; Lin, HY; Lin, TC | 1 |
| Bessonova, L; Cichewicz, A; Doane, MJ; Harvey, PD; Hughes, R; Martin, A; O'Sullivan, AK; Snook, K; Weiden, PJ | 1 |
| Krishnegowda, S; Udaykumar, P; Yadiyal, A | 1 |
| Chen, B; Ma, X; Wang, M; Yan, Y; Yang, X; Yin, L | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Hartikainen, S; Koponen, M; Lilja, S; Tiihonen, M; Tolppanen, AM | 1 |
| Hefner, G; Klimke, A; Reißner, P; Toto, S; Wolff, J | 1 |
| Brand, BA; Gangadin, S; Sommer, IE; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
| Nabekura, T; Uwai, Y | 1 |
| Masauji, T; Shimizu, Y; Taga, M; Takahashi, Y; Yamamoto, Y | 1 |
| Chen, Q; Deng, W; Du, X; Hao, Q; Hu, X; Li, C; Li, K; Li, L; Li, T; Li, X; Lu, T; Lv, L; Ma, X; Ren, H; Tan, L; Tan, Q; Tang, Y; Wang, C; Wang, L; Wang, Q; Wang, Y; Wu, Y; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Aarsland, D; Ballard, C; Creese, B; Mueller, C; Rogowska, M; Stewart, R; Thornton, M; Tsamakis, K; Velayudhan, L | 1 |
| Chen, Q; Coid, J; Deng, W; Guo, W; Li, K; Li, L; Li, T; Lu, T; Lv, L; Ma, X; Tan, L; Tan, Q; Tao, S; Wang, C; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Carvalho, AF; Hsu, CW; Hsu, TW; Liang, CS; Thompson, T; Tsai, TC; Tseng, PT; Yu, CL | 1 |
| Blanchet, C; Carretier, E; Guessoum, SB; Ludot, M; Moro, MR; Thorey, S | 1 |
| Carlson, HE; Correll, CU; Kazimi, MM; Koch, MT | 1 |
| Bayraktutan, Z; Bulent Yazici, A; Cadirci, E; Cinar, I; Dincer, B; Selli, J; Toktay, E; Yazici, E | 1 |
| Burschinski, A; Davis, JM; Leucht, S; Priller, J; Schneider-Thoma, J; Siafis, S; Wang, D; Wu, H | 1 |
| Bateman, BT; Ely, EW; Inouye, SK; Jones, RN; Kim, DH; Lee, SB; Levin, R; Marcantonio, ER; Metzger, E; Pandharipande, PP; Park, CM; Pisani, MA | 1 |
| Assunção, AJ; Beirão, EMDCSP; Marques, RM; Matos, CRC; Neves, RS | 1 |
180 review(s) available for risperidone and quetiapine fumarate
| Article | Year |
|---|---|
Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy.
Topics: Amnesia; Antipsychotic Agents; Cholinergic Antagonists; Clozapine; Dibenzothiazepines; Humans; Mental Recall; Neuropsychological Tests; Quetiapine Fumarate; Retention, Psychology; Risperidone; Schizophrenia; Schizophrenic Psychology | 1996 |
[New antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Clinical Trials as Topic; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Pramipexole; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 1997 |
Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Cost-Benefit Analysis; Dibenzothiazepines; Drug Approval; Health Care Costs; Health Status; Hospitalization; Humans; Meta-Analysis as Topic; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States; United States Food and Drug Administration | 1998 |
Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Central Nervous System Diseases; Clozapine; Dibenzothiazepines; Drug Interactions; Dyskinesia, Drug-Induced; Health Status; Humans; Hypotension, Orthostatic; Olanzapine; Pirenzepine; Quality of Life; Quetiapine Fumarate; Receptors, Cholinergic; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Sleep Wake Disorders; Treatment Refusal; Weight Gain | 1998 |
Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Humans; Olanzapine; Parkinson Disease, Secondary; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Substance Withdrawal Syndrome | 1998 |
Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Cognition Disorders; Dibenzothiazepines; Humans; Neuropsychological Tests; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1998 |
Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Adult; Age Factors; Aged; Algorithms; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Decision Trees; Dementia; Dibenzothiazepines; Female; Humans; Male; Mood Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1998 |
Common treatment goals of antipsychotics: acute treatment.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Hospitalization; Humans; Length of Stay; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology | 1998 |
Conventional vs. newer antipsychotics in elderly patients.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 1999 |
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 1999 |
Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Disease Progression; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Research Design; Risperidone | 1999 |
Cognitive improvement in schizophrenia with novel antipsychotic medications.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index | 1999 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 1999 |
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
Topics: Amoxapine; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine Antagonists; Haloperidol; Humans; In Vitro Techniques; Loxapine; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Tomography, Emission-Computed | 1999 |
Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Humans; Olanzapine; Pirenzepine; Practice Guidelines as Topic; Quetiapine Fumarate; Risperidone; Schizophrenia; Terminology as Topic | 1999 |
Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials.
Topics: Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Confidence Intervals; Dibenzothiazepines; Humans; Odds Ratio; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome | 1999 |
Drug metabolism and atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1999 |
Pharmacologic treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quality of Life; Quetiapine Fumarate; Recurrence; Risperidone; Schizophrenia | 1999 |
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
New antipsychotic medications: more than old wine and new bottles.
Topics: Agranulocytosis; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia | 2000 |
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Depression; Depressive Disorder; Dibenzothiazepines; Hostility; Humans; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Suicide; Thiazoles; Treatment Outcome | 2000 |
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brain; Clozapine; Dibenzothiazepines; Humans; Movement Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risk Factors; Risperidone | 2000 |
Antipsychotic drug side effect issues in bipolar manic patients.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2000 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
[Atypical antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Netherlands; Olanzapine; Pirenzepine; Psychopharmacology; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Agents | 2000 |
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Sulpiride | 2000 |
New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
Consistency of atypical antipsychotic superiority to placebo in recent clinical trials.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Health Care Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2001 |
Ziprasidone: a new atypical antipsychotic.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Dopamine Antagonists; Drug Interactions; Guidelines as Topic; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Thiazoles; Time Factors; Tourette Syndrome | 2001 |
Atypical antipsychotics: impaired glucose metabolism.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Glucose; Humans; Male; Metabolic Diseases; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2001 |
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Models, Neurological; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Broad therapeutic uses of atypical antipsychotic medications.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child Development Disorders, Pervasive; Clozapine; Dementia; Dibenzothiazepines; Humans; Mood Disorders; Olanzapine; Personality Disorders; Pirenzepine; Quetiapine Fumarate; Risperidone | 2001 |
Use of atypical antipsychotics in mood disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles | 2001 |
[Clinical and pharmacological studies of the second generation antipsychotics].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Cytoskeletal Proteins; Dibenzothiazepines; Dopamine; Dopamine Antagonists; Humans; Nerve Tissue Proteins; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists | 2001 |
Atypical antipsychotics in Parkinson-sensitive populations.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Dementia, Vascular; Dibenzothiazepines; Hallucinations; Humans; Iatrogenic Disease; Lewy Body Disease; Olanzapine; Parkinson Disease; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2002 |
Atypical antipsychotics: experience and use in the elderly.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Dementia; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; United Kingdom | 2002 |
Pharmacotherapy of bipolar disorder: the role of atypical antipsychotics and experimental strategies.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Safety in treating bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyskinesias; Haloperidol; Humans; Hyperglycemia; Hyperprolactinemia; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Thioridazine; Weight Gain | 2003 |
Pharmacological approaches to the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.
Topics: Adult; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Black or African American; Bone Marrow Diseases; Child; Dibenzothiazepines; Endocrine System Diseases; Humans; Mental Disorders; Nervous System Diseases; Olanzapine; Piperazines; Pirenzepine; Primary Health Care; Quetiapine Fumarate; Risperidone; Thiazoles | 2003 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Therapeutic Equivalency; Thiazoles | 2003 |
[An introduction to antipsychotics].
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine Antagonists; Humans; Indoles; Isoindoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Thiazoles | 2003 |
[Extrapyramidal syndrome].
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dystonia; Humans; Indoles; Isoindoles; Parkinsonian Disorders; Quetiapine Fumarate; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Syndrome; Thiazoles | 2003 |
Antipsychotic medication and seizures: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2003 |
[The appearance of metabolic syndrome in treatment with atypical antipsychotics].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Clinical Trials as Topic; Clozapine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Glucose; Haloperidol; Humans; Intellectual Disability; Male; Mental Disorders; Metabolic Syndrome; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain | 2003 |
Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk; Risperidone; Schizophrenia | 2004 |
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
Topics: Antipsychotic Agents; Benzodiazepines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Clozapine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Molecular Structure; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2004 |
Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Piperazines; Polypharmacy; Quetiapine Fumarate; Quinolones; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
New antipsychotics and schizophrenia: a review on efficacy and side effects.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Cognition; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders | 2004 |
Atypical antipsychotics and diabetes mellitus.
Topics: Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus; Dibenzothiazepines; Glucose; Humans; Insulin Resistance; Islets of Langerhans; Obesity; Olanzapine; Pancreas; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2004 |
Tardive dyskinesia rates with atypical antipsychotics in older adults.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Incidence; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2004 |
Efficacy of atypical antipsychotics in elderly patients with dementia.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2004 |
Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Humans; Lewy Body Disease; Olanzapine; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2004 |
The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
Topics: Aged; Antipsychotic Agents; Choice Behavior; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Double-Blind Method; Homes for the Aged; Humans; Mental Disorders; Nursing Homes; Practice Patterns, Physicians'; Quality of Life; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
Pharmacology of antipsychotics in the elderly: a focus on atypicals.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Serotonin Antagonists; Thiazoles; Treatment Outcome; United States | 2004 |
Optimizing atypical antipsychotic treatment strategies in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Olanzapine; Parkinson Disease; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2004 |
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Industry; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Support as Topic; Retrospective Studies; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
[Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Benzodiazepines; Bipolar Disorder; Cognition; Dibenzothiazepines; Drug Design; Drug Resistance; Drug Therapy, Combination; Female; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2004 |
Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.
Topics: Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone | 2005 |
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Counseling; Dibenzothiazepines; Family Planning Services; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Teratogens; Triazines; Valproic Acid; Women's Health | 2005 |
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; MEDLINE; Neuropsychological Tests; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
Atypical antipsychotics: newer options for mania and maintenance therapy.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid | 2005 |
Antipsychotic poisoning in young children: a systematic review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Chlorpromazine; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Infant; Infant, Newborn; Olanzapine; Pimozide; Piperazines; Poisoning; Quetiapine Fumarate; Quinolones; Risperidone | 2005 |
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2005 |
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Refusal | 2005 |
Typical and atypical antipsychotics in bipolar depression.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Administration Schedule; Humans; Olanzapine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Severity of Illness Index; Treatment Outcome | 2005 |
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Topics: Aggression; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2006 |
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Bias; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Industry; Humans; Olanzapine; Patient Selection; Publication Bias; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Research Support as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2006 |
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Topics: Antipsychotic Agents; Body Weight; Clozapine; Dibenzothiazepines; Humans; Hyperlipidemias; Leptin; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Weight Gain | 2005 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Haloperidol; Humans; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Tic Disorders; Treatment Outcome | 2006 |
Atypical antipsychotics in the management of delirium: a review of the empirical literature.
Topics: Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2005 |
Creating more effective antidepressants: clues from the clinic.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder, Major; Dibenzothiazepines; Drug Design; Drug Synergism; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Histamine; Receptors, Serotonin; Risperidone; Stress Disorders, Post-Traumatic | 2006 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Long-term use of atypical antipsychotics in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States | 2006 |
Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Outcome | 2006 |
Treatment of psychosis: 30 years of progress.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2006 |
[Application of neuroleptics for dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Dementia; Dibenzothiazepines; Drug Approval; Humans; Mental Disorders; Olanzapine; Quetiapine Fumarate; Risk; Risperidone; United States; United States Food and Drug Administration | 2007 |
An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dibenzothiazepines; Female; Haloperidol; Humans; Incidence; Male; Middle Aged; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2007 |
Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
Topics: Antipsychotic Agents; Benzodiazepines; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Follow-Up Studies; Humans; Mental Disorders; Olanzapine; Quetiapine Fumarate; Risperidone | 2007 |
Metabolic effects of the atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Managing the acutely agitated and psychotic patient.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.
Topics: Adolescent; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Female; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2008 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome | 2008 |
Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2008 |
Problems with CATIE. Phase 1: Looking back--what the clinician needs to know.
Topics: Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials, Phase I as Topic; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Risperidone; Schizophrenia; Thiazoles | 2008 |
The use of atypical antipsychotics in pediatric bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain | 2008 |
Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Dibenzothiazepines; Disorders of Excessive Somnolence; Headache; Humans; Methylphenidate; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2008 |
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
[Atypical antipsychotics in first-episode psychosis: a review].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index | 2008 |
[The use of antipsychotics in patients with dementia].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, Vascular; Dibenzothiazepines; Double-Blind Method; Evidence-Based Medicine; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2008 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cardiovascular System; Dibenzothiazepines; Drug Overdose; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2009 |
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Quetiapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2010 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Antipsychotics in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes, Gestational; Dibenzothiazepines; Female; Humans; Infant, Newborn; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
Management of hallucinations and psychosis in Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Comorbidity; Delusions; Dementia; Depression; Dibenzothiazepines; Disease Progression; Guidelines as Topic; Hallucinations; Humans; Middle Aged; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Report; Risperidone | 2010 |
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
Topics: Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Isoxazoles; Meta-Analysis as Topic; Paliperidone Palmitate; Piperazines; Placebos; Pyrimidines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Review Literature as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Clozapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2010 |
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Topics: Adult; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Sulpiride | 2011 |
Second-generation antipsychotics for anxiety disorders.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2010 |
Second-generation antipsychotics for major depressive disorder and dysthymia.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dysthymic Disorder; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride | 2010 |
Second-generation antipsychotics for obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Obsessive-Compulsive Disorder; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
A review of atypical antipsychotic medications for posttraumatic stress disorder.
Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Dibenzothiazepines; Humans; Quetiapine Fumarate; Risperidone; Stress Disorders, Post-Traumatic | 2011 |
[Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium Carbonate; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2012 |
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
Topics: Adult; Affective Disorders, Psychotic; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Hypercholesterolemia; Incidence; Pharmacovigilance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2012 |
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Weight Gain | 2012 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child, Preschool; Dibenzothiazepines; Humans; Intellectual Disability; Quetiapine Fumarate; Risperidone | 2012 |
Atypical antipsychotics for the treatment of disruptive behavior.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Olanzapine; Pediatrics; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
Atypical antipsychotics in the treatment of delirium.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles | 2013 |
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2014 |
Quetiapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2013 |
Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Generalization, Psychological; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2014 |
The pharmacologic management of delirium in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Delirium; Dexmedetomidine; Dibenzothiazepines; Humans; Melatonin; Olanzapine; Quetiapine Fumarate; Risperidone | 2014 |
Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chemotherapy, Adjuvant; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Synergism; Humans; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Remission Induction; Risperidone; Treatment Outcome; Young Adult | 2014 |
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2014 |
Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Schizophrenia | 2015 |
Management of delirium in palliative care: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cholinesterase Inhibitors; Delirium; Disease Management; Haloperidol; Health Personnel; Humans; Olanzapine; Palliative Care; Quetiapine Fumarate; Risperidone | 2015 |
Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review.
Topics: Antipsychotic Agents; Critical Care; Critical Illness; Delirium; Dexmedetomidine; Haloperidol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypnotics and Sedatives; Intensive Care Units; Length of Stay; Neuroprotective Agents; Postoperative Complications; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Rivastigmine; Treatment Outcome | 2015 |
Antipsychotic use in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Maternal-Fetal Exchange; Mental Disorders; Olanzapine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; Quetiapine Fumarate; Risperidone | 2015 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Antipsychotic medications for cocaine dependence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cocaine-Related Disorders; Haloperidol; Humans; Lamotrigine; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reserpine; Risperidone; Triazines | 2016 |
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2016 |
Risperidone (depot) for schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delayed-Action Preparations; Humans; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2016 |
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Panic Disorder; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2016 |
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Behavioral Disorders in Dementia: Appropriate Nondrug Interventions and Antipsychotic Use.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Behavior Therapy; Benzodiazepines; Cognitive Behavioral Therapy; Dementia; Emotions; Humans; Hypotension, Orthostatic; Metabolic Syndrome; Neuroleptic Malignant Syndrome; Olanzapine; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2016 |
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2017 |
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea | 2017 |
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Weight Gain | 2017 |
Delirium in hospitalized patients: Risks and benefits of antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Haloperidol; Hospitalization; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2017 |
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles | 2018 |
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Administration, Oral; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Oxcarbazepine; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tranquilizing Agents; Valproic Acid | 2018 |
Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?
Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Bipolar Disorder; Female; Humans; North America; Olanzapine; Quetiapine Fumarate; Risperidone; United States; Weight Gain | 2020 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Antipsychotics in Postpartum Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Humans; Olanzapine; Postpartum Period; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2020 |
Second Generation Antipsychotics Monotherapy as Maintenance Treatment for Bipolar Disorder: a Systematic Review of Long-Term Studies.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2020 |
Augmentation with Atypical Antipsychotics for Treatment-Resistant Depression.
Topics: Antipsychotic Agents; Benzodiazepines; Depression; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2021 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2021 |
Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Humans; Off-Label Use; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2022 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dementia; Humans; Network Meta-Analysis; Off-Label Use; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2022 |
Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2023 |
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Female; Humans; Male; Mice; Olanzapine; Quetiapine Fumarate; Rats; Risperidone | 2022 |
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic | 2022 |
Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States.
Topics: Adult; Antipsychotic Agents; Financial Stress; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; United States | 2022 |
Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Network Meta-Analysis; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2023 |
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2023 |
Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review.
Topics: Adolescent; Adult; Anorexia Nervosa; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2023 |
Antipsychotic-induced akathisia in adults with acute schizophrenia: A systematic review and dose-response meta-analysis.
Topics: Adult; Aged; Antipsychotic Agents; Humans; Psychomotor Agitation; Quetiapine Fumarate; Risperidone; Schizophrenia | 2023 |
123 trial(s) available for risperidone and quetiapine fumarate
| Article | Year |
|---|---|
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Dibenzothiazepines; Female; Humans; Male; Neuronal Ceroid-Lipofuscinoses; Olanzapine; Pilot Projects; Pirenzepine; Quetiapine Fumarate; Risperidone | 2001 |
A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology | 2001 |
The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thioridazine | 2002 |
Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Multivariate Analysis; Olanzapine; Pirenzepine; Prospective Studies; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Single-Blind Method | 2002 |
Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
Topics: Ambulatory Care; Antipsychotic Agents; Dibenzothiazepines; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2002 |
Comparison of three antipsychotics in the emergency psychiatric setting.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Emergency Services, Psychiatric; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sampling Studies; Treatment Outcome | 2003 |
A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.
Topics: Adolescent; Adult; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2004 |
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
Topics: Adolescent; Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Biotransformation; Clozapine; Dibenzothiazepines; Electrocardiography; Female; Haloperidol; Heart Conduction System; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Thioridazine | 2004 |
A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2004 |
Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Health Status; Hospitalization; Humans; Indoles; Isoindoles; Japan; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sleep; Thiazoles | 2004 |
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Female; Fluphenazine; Humans; Male; Middle Aged; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thyroid Diseases; Thyroid Function Tests; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine | 2005 |
Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Olanzapine; Polysomnography; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Sleep Stages; Thiazoles | 2005 |
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors | 2005 |
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Female; Haloperidol; Hostility; Humans; Male; Olanzapine; Outpatients; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Cultural Comparison; Dibenzothiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; International Classification of Diseases; Male; Olanzapine; Patient Compliance; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome | 2005 |
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2005 |
Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Time Factors; Treatment Outcome | 2005 |
A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Orgasm; Patient Compliance; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Behavior; Sexual Dysfunction, Physiological | 2006 |
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology | 2005 |
Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Population Surveillance; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Time Factors | 2005 |
Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Health Surveys; Humans; Male; Odds Ratio; Olanzapine; Outpatients; Prevalence; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological; Time; Treatment Outcome | 2006 |
Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Canada; Clozapine; Cohort Studies; Cost of Illness; Cost-Benefit Analysis; Dibenzothiazepines; Drug Costs; Female; Health Care Surveys; Health Resources; Humans; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risperidone; Schizophrenia | 2006 |
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cross-Over Studies; Dibenzothiazepines; Drug Monitoring; Drug Resistance; Eosinophilia; Female; Follow-Up Studies; Humans; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2006 |
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Chronic Disease; Cross-Over Studies; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Thiazoles; Time Factors; Treatment Outcome | 2006 |
Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Evaluation; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2006 |
The effect of long-term antipsychotic treatment on prolactin.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Cross-Sectional Studies; Dibenzothiazepines; Female; Humans; Male; Mental Disorders; Olanzapine; Prolactin; Quetiapine Fumarate; Risperidone | 2006 |
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Quetiapine Fumarate; Risperidone; Schizophrenia | 2006 |
Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Cognition Disorders; Dibenzothiazepines; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Male; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2006 |
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Mental Disorders; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Survival Analysis; Treatment Outcome | 2006 |
Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 2006 |
Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cognition Disorders; Dibenzothiazepines; Double-Blind Method; Emotions; Facial Expression; Female; Humans; Interpersonal Relations; Male; Middle Aged; Neuropsychological Tests; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Social Perception; Time Factors; Treatment Outcome | 2006 |
Effectiveness of switching antipsychotic medications.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Dibenzothiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Olanzapine; Patient Dropouts; Psychotherapy; Quetiapine Fumarate; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Selection Bias; Survival Analysis; Treatment Outcome | 2006 |
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Perphenazine; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
Topics: Adaptation, Psychological; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Follow-Up Studies; Health Status; Humans; National Institute of Mental Health (U.S.); Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Treatment Outcome; United States | 2007 |
A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cross-Over Studies; Dibenzothiazepines; Electroencephalography; Fourier Analysis; Haloperidol; Humans; Indoles; Isoindoles; Male; Olanzapine; Quetiapine Fumarate; Reference Values; Risperidone; Single-Blind Method; Thiazoles; Time Factors | 2007 |
Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Dibenzothiazepines; Female; Humans; Male; Mental Disorders; Mental Status Schedule; Middle Aged; Mood Disorders; Neuropsychological Tests; Perceptual Disorders; Quetiapine Fumarate; Risperidone; Single-Blind Method; Thinking; Treatment Outcome | 2007 |
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Cohort Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2007 |
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sleep Stages; Sleep Wake Disorders; Treatment Outcome; Weight Gain | 2007 |
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Topics: Adult; Antipsychotic Agents; Attitude to Health; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Status; Humans; Least-Squares Analysis; Male; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Treatment Outcome | 2007 |
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attention; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Double-Blind Method; Electrocardiography; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Reaction Time; Risperidone; Schizophrenia; Schizophrenic Psychology; Verbal Learning | 2007 |
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Topics: Administration, Oral; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Lithium Compounds; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2007 |
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
Topics: Adult; Algorithms; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.
Topics: Adult; Antipsychotic Agents; Attention; Bipolar Disorder; Cognition; Cognition Disorders; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Memory; Middle Aged; Quetiapine Fumarate; Reaction Time; Risperidone; Sleep Stages; Sleep Wake Disorders | 2007 |
Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Dibenzothiazepines; Emergency Services, Psychiatric; Female; Haloperidol; Hostility; Humans; Italy; Male; Middle Aged; Olanzapine; Prospective Studies; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.
Topics: Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Humans; Placebos; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2007 |
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists.
Topics: Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Humans; Olanzapine; Perphenazine; Piperazines; Psychiatry; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors | 2007 |
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Female; Humans; Hyperprolactinemia; Middle Aged; Olanzapine; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2007 |
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Olanzapine; Patient Dropouts; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Time Factors; Treatment Outcome; Treatment Refusal | 2008 |
Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Sexual Dysfunctions, Psychological | 2008 |
Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
Topics: Adult; Antipsychotic Agents; Attitude to Health; Benzodiazepines; Cognition Disorders; Culture; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Refusal | 2008 |
Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Europe; Female; Humans; Male; Middle Aged; Obesity; Olanzapine; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Self Concept; Social Adjustment | 2008 |
A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunction, Physiological; Spain; Time Factors; Treatment Outcome | 2008 |
What CATIE found: results from the schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychology; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2008 |
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
Topics: Activities of Daily Living; Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Cognition Disorders; Dibenzothiazepines; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Psychomotor Agitation; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risperidone; Surveys and Questionnaires | 2008 |
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2008 |
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Polypharmacy; Quetiapine Fumarate; Risperidone; Schizophrenia | 2008 |
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.
Topics: Adolescent; Benzodiazepines; Blood Glucose; Body Mass Index; Child; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Obesity; Olanzapine; Prevalence; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Substance-Related Disorders; Thyroxine; Triglycerides | 2008 |
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Demography; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Double-Blind Method; Electrocardiography; Female; Humans; Male; Methamphetamine; Middle Aged; Quetiapine Fumarate; Risperidone | 2008 |
A comparative pilot study of second-generation antipsychotics in children and adolescents with schizophrenia-spectrum disorders.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Olanzapine; Pilot Projects; Psychiatric Status Rating Scales; Quetiapine Fumarate; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 2008 |
Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Olanzapine; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Treatment Outcome; Weight Gain | 2008 |
Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholesterol; Chronic Disease; Dibenzothiazepines; Drug Tolerance; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Triglycerides; Young Adult | 2009 |
Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperazines; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2008 |
Results of phase 3 of the CATIE schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2009 |
The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Patient Satisfaction; Piperazines; Prolactin; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Treatment Outcome | 2008 |
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholesterol, HDL; Cholesterol, LDL; Dibenzothiazepines; Female; Glucose; Humans; Insulin; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Triglycerides; Young Adult | 2009 |
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Mental Disorders; Obesity; Olanzapine; Quetiapine Fumarate; Risperidone | 2009 |
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2009 |
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Chromosomes, Human, Pair 4; Dibenzothiazepines; Double-Blind Method; Follow-Up Studies; Genome-Wide Association Study; Humans; Olanzapine; Perphenazine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents.
Topics: Adolescent; Adolescent Behavior; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Weight Gain | 2010 |
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Headache; Humans; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2009 |
Hunger and negative alliesthesia to aspartame and sucrose in patients treated with antipsychotic drugs and controls.
Topics: Adult; Antipsychotic Agents; Aspartame; Benzodiazepines; Carbonated Beverages; Clozapine; Dibenzothiazepines; Double-Blind Method; Food Preferences; Humans; Hunger; Male; Middle Aged; Olanzapine; Pleasure; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sucrose; Surveys and Questionnaires; Sweetening Agents; Taste; Time Factors; Young Adult | 2009 |
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Galactorrhea; Hospitalization; Humans; Length of Stay; Male; Olanzapine; Patient Readmission; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Thiazoles; Treatment Outcome | 2010 |
Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dibenzothiazepines; Female; Humans; Injections, Intramuscular; Male; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Secondary Prevention | 2010 |
Esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia.
Topics: Adult; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Single-Blind Method; Time Factors; Treatment Outcome; Young Adult | 2010 |
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Movement Disorders; Olanzapine; Perphenazine; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles; Treatment Outcome | 2011 |
Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys.
Topics: Adaptation, Physiological; Animals; Antipsychotic Agents; Behavior, Animal; Cohort Studies; Dibenzothiazepines; Discrimination, Psychological; Dose-Response Relationship, Drug; Feedback, Psychological; Macaca nemestrina; Male; Neuropsychological Tests; Quetiapine Fumarate; Risperidone | 2011 |
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis.
Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2011 |
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Disease Progression; Double-Blind Method; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Neuropsychological Tests; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Risperidone | 2011 |
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dibenzothiazepines; Diet, Reducing; Drug Substitution; Exercise; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides | 2011 |
Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Drug Delivery Systems; Female; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Secondary Prevention; Time Factors | 2012 |
DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers.
Topics: Antipsychotic Agents; Area Under Curve; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Polymorphism, Genetic; Prolactin; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D3; Regression Analysis; Risperidone; Sex Factors | 2011 |
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzodiazepines; Depression; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 2011 |
Driving ability under sertindole.
Topics: Adult; Antipsychotic Agents; Automobile Driving; Dibenzothiazepines; Female; Humans; Imidazoles; Indoles; Male; Middle Aged; Psychomotor Performance; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Visual Perception | 2012 |
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Olanzapine; Patient Acceptance of Health Care; Patient Dropouts; Patient Participation; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Characteristics | 2012 |
One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; China; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Quetiapine Fumarate; Risperidone; Schizophrenia; Time Factors | 2012 |
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Therapeutic Equipoise; Triglycerides; United States | 2013 |
Clozapine and visuospatial processing in treatment-resistant schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Cognition Disorders; Dibenzothiazepines; Drug Resistance; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Space Perception; Young Adult | 2013 |
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Coronary Artery Disease; Dibenzothiazepines; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2013 |
Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Healthy Volunteers; Humans; Huntingtin Protein; Male; Nerve Tissue Proteins; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone | 2013 |
Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Drug Monitoring; Drug Resistance; Extrapyramidal Tracts; Female; Humans; Incidence; Intention to Treat Analysis; Lost to Follow-Up; Male; Middle Aged; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Therapeutic Equivalency | 2013 |
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hallucinations; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2013 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2014 |
Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Sample Size; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Outpatients; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: a randomized, open-label, parallel-group, flexible-dose study.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Depression; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cataract; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2015 |
Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Depression; Dibenzothiazepines; Female; Humans; Italy; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome | 2015 |
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Female; Genotyping Techniques; Glucagon-Like Peptide-1 Receptor; Haplotypes; Humans; Male; Models, Genetic; Olanzapine; Perphenazine; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Receptors, Glucagon; Regression Analysis; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain; White People | 2014 |
Schizophrenia gene expression profile reverted to normal levels by antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Longitudinal Studies; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Transcriptome; Treatment Outcome | 2014 |
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Depressive Disorder, Major; Double-Blind Method; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2015 |
Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biological Assay; Chromatography, Liquid; Haloperidol; Humans; Male; Mass Spectrometry; Medication Adherence; Middle Aged; Olanzapine; Pilot Projects; Quetiapine Fumarate; Risperidone | 2015 |
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
Topics: Adolescent; Adult; Aged; Alcoholism; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Substance-Related Disorders; Thiazoles; Young Adult | 2015 |
Comparison of Quetiapine and Risperidone in Treatment of Acute Psychosis: A Double-Blind, Randomized-Controlled Study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Young Adult | 2015 |
Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Body Mass Index; Conduct Disorder; Female; Humans; Male; Prolactin; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Treatment Outcome | 2015 |
Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Child; Child, Preschool; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Longitudinal Studies; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone | 2016 |
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Veins; Young Adult | 2016 |
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Middle Aged; Non-alcoholic Fatty Liver Disease; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2016 |
Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Delayed-Action Preparations; Female; Haloperidol; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2016 |
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Time Factors; Treatment Outcome | 2017 |
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2017 |
The validity and sensitivity of PANSS-6 in treatment-resistant schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Humans; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Quetiapine Fumarate; Reproducibility of Results; Risperidone; Schizophrenia; Sensitivity and Specificity | 2018 |
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial.
Topics: Adult; Antipsychotic Agents; Body-Weight Trajectory; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2019 |
Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Biosensing Techniques; Cloud Computing; Humans; Medical Informatics Applications; Medication Adherence; Mobile Applications; Multicenter Studies as Topic; Olanzapine; Pragmatic Clinical Trials as Topic; Psychiatry; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Tablets; United Kingdom | 2019 |
Examination of heterogeneity in treatment response to antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Deprescriptions; Female; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Mental Status and Dementia Tests; Olanzapine; Perphenazine; Proportional Hazards Models; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2019 |
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2020 |
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
Topics: Adult; Alcoholism; Antipsychotic Agents; Comorbidity; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Symptom Flare Up; Thiazoles; Time Factors | 2020 |
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2020 |
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Glucose; Haloperidol; Humans; Inflammation; Olanzapine; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2024 |
382 other study(ies) available for risperidone and quetiapine fumarate
| Article | Year |
|---|---|
Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Male; Mesencephalon; Neurons; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Substantia Nigra; Thiazoles | 1995 |
Seroquel restores sensorimotor gating in phencyclidine-treated rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Haloperidol; Male; Phencyclidine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Reflex, Startle; Risperidone | 1996 |
BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; CHO Cells; Clozapine; Corpus Striatum; COS Cells; Cricetinae; Dibenzothiazepines; Dopamine; Female; Guinea Pigs; Haloperidol; Indoles; Kidney; Male; Microdialysis; Neuroblastoma; Nucleus Accumbens; Olanzapine; Piperazines; Pirenzepine; Prefrontal Cortex; Pyridines; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Tritium; Tumor Cells, Cultured | 1997 |
The new antipsychotic compounds: is a clinical choice algorithm possible?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1998 |
Two new atypical antipsychotics: advantages and disadvantages.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1998 |
Novel antipsychotic medications in the treatment of children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child Psychiatry; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; United States | 1999 |
Risperidone and clozapine for treatment-resistant schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Dibenzothiazepines; Humans; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 1999 |
Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Pirenzepine; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 1999 |
Quetiapine in adolescent psychosis.
Topics: Adolescent; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 1999 |
Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Topics: Animals; Antipsychotic Agents; Benzazepines; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Fever; Hypothermia; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Risperidone; Time Factors | 2000 |
Discriminant cognitive factors in responder and non-responder patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Clozapine; Cognition Disorders; Dibenzothiazepines; Female; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retention, Psychology; Risperidone; Schizophrenia; Schizophrenic Language; Schizophrenic Psychology; Treatment Outcome; Verbal Behavior | 1999 |
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Patient Satisfaction; Piperazines; Pirenzepine; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 1999 |
Tardive dyskinesia in older patients.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone | 2000 |
Side Effects of Antipsychotic Medications: Physician's Choice of Medication and Patient Compliance. Dallas, Texas, California. January 22, 1999. Proceedings of a roundtable.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Pirenzepine; Practice Patterns, Physicians'; Quality of Life; Quetiapine Fumarate; Risperidone | 2000 |
Side effects of antipsychotics in the elderly.
Topics: Age Factors; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Clozapine; Comorbidity; Dementia; Dibenzothiazepines; Humans; Movement Disorders; Neuroleptic Malignant Syndrome; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2000 |
Novel antipsychotic use in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Drug Administration Schedule; Humans; Olanzapine; Piperazines; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2000 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Dibenzothiepins; Dyskinesia, Drug-Induced; Germany; Humans; Neurotransmitter Agents; Olanzapine; Patient Compliance; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical antipsychotics for treatment of mixed depression and anxiety.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Comorbidity; Depressive Disorder; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2000 |
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Carrier Proteins; Caudate Nucleus; Cocaine; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Olanzapine; Paroxetine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tritium | 2000 |
Risperidone and withdrawal dyskinesia.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Male; Quetiapine Fumarate; Risperidone; Substance Withdrawal Syndrome; Treatment Outcome | 2000 |
Combination risperidone and quetiapine therapy in refractory schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Failure | 2001 |
Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain Chemistry; Dibenzothiazepines; Dopamine Antagonists; Image Processing, Computer-Assisted; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone | 2001 |
Hypothesis and hypothesis testing in the clinical trial.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Humans; Olanzapine; Periodicals as Topic; Pirenzepine; Psychotic Disorders; Publishing; Quetiapine Fumarate; Reproducibility of Results; Research Design; Risperidone; Schizophrenia; Terminology as Topic | 2001 |
Cataracts and quetiapine.
Topics: Adult; Antipsychotic Agents; Cataract; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Long QT Syndrome; Quetiapine Fumarate; Risperidone; Time Factors | 2001 |
Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding Sites; Binding, Competitive; Cell Line; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Haloperidol; Humans; Neurons; Norepinephrine; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Thiazoles | 2001 |
Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database.
Topics: Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Databases as Topic; Dibenzothiazepines; Drug Approval; Humans; Incidence; Olanzapine; Pirenzepine; Placebos; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Suicide; Suicide, Attempted; Treatment Outcome; United States; United States Food and Drug Administration | 2001 |
Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.
Topics: Animals; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Haloperidol; HeLa Cells; Humans; Ileum; In Vitro Techniques; Indoles; Lysergic Acid; Muscle Contraction; Olanzapine; Ondansetron; Pirenzepine; Quetiapine Fumarate; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfur Radioisotopes; Tritium; Tropisetron | 2001 |
Quetiapine for tic disorder: a case report.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Haloperidol; Humans; Quetiapine Fumarate; Risperidone; Tic Disorders | 2001 |
Effects of antipsychotic drugs on operant responding after acute and repeated administration.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Conditioning, Operant; Dibenzothiazepines; Dose-Response Relationship, Drug; Haloperidol; Imidazoles; Indoles; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Remoxipride; Risperidone; Thioridazine; Time Factors | 2002 |
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.
Topics: Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Fructose; Humans; Lamotrigine; Male; Obesity; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Triazines | 2002 |
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risk Factors; Risperidone; Schizophrenia | 2002 |
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Cerebellar Cortex; Dibenzothiazepines; Dose-Response Relationship, Drug; Entorhinal Cortex; Hippocampus; Infusion Pumps; Male; Nucleus Accumbens; Olanzapine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors | 2002 |
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.
Topics: Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Kinetics; Olanzapine; Pirenzepine; Quetiapine Fumarate; Recombinant Proteins; Risperidone | 2002 |
Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Hospitals, Veterans; Humans; Male; Middle Aged; New York City; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Urban Population; Veterans | 2002 |
[General practice study with atypical neuroleptics. Differences in tolerance].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dibenzothiazepines; Family Practice; Humans; Multicenter Studies as Topic; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2002 |
Restless legs syndrome probably induced by risperidone treatment.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Polysomnography; Quetiapine Fumarate; Restless Legs Syndrome; Risperidone; Sleep; Valproic Acid | 2002 |
Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Blotting, Northern; Cell Culture Techniques; Cell Survival; Clozapine; Dibenzothiazepines; PC12 Cells; Quetiapine Fumarate; Rats; Receptor, Nerve Growth Factor; Receptors, Nerve Growth Factor; Risperidone; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1 | 2002 |
Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Dibenzothiazepines; Drinking; Female; Haloperidol; Learning; Male; Olanzapine; Pirenzepine; Pregnancy; Prenatal Exposure Delayed Effects; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Retention, Psychology; Risperidone; Spatial Behavior | 2002 |
The value of atypical antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Drug Labeling; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Safety; Schizophrenia; Thiazoles; United States | 2002 |
The effects of novel antipsychotics on glucose and lipid levels.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Haloperidol; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Triglycerides; Weight Gain | 2002 |
Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain; Dibenzothiazepines; Infusions, Intravenous; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors; Tritium | 2002 |
Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Utilization; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Registries; Risperidone; Schizophrenia; Sex Distribution; Socioeconomic Factors; United States; United States Department of Veterans Affairs | 2002 |
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dibenzothiazepines; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Psychological; Haloperidol; Loxapine; Quetiapine Fumarate; Quinoxalines; Rats; Rats, Wistar; Risperidone; Sulpiride | 2002 |
Prescribing second-generation antipsychotics and the evolving standard of care in Italy.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Benzodiazepines; Brief Psychiatric Rating Scale; Clozapine; Community Mental Health Services; Dibenzothiazepines; Drug Therapy, Combination; Drug Utilization; Female; Humans; Italy; Male; Middle Aged; Olanzapine; Outpatients; Pharmacoepidemiology; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2002 |
Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Topics: Adolescent; Adult; Antipsychotic Agents; Citalopram; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2002 |
Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapine.
Topics: Adult; Comorbidity; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Quetiapine Fumarate; Risperidone; Schizophrenia | 2003 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Dibenzothiazepines; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Leptin; Male; Obesity; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides; Weight Gain | 2003 |
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Spain; Weight Gain | 2003 |
Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cost Savings; Dibenzothiazepines; Drug Costs; Drug Utilization Review; Female; Geriatric Assessment; Health Services Research; Humans; Length of Stay; Male; Mental Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; United States | 2003 |
Use of atypical antipsychotic drugs in patients with dementia.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Comorbidity; Dementia; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2003 |
Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Risperidone | 2003 |
Delusions of pregnancy associated with increased prolactin concentrations produced by antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benztropine; Delusions; Dibenzothiazepines; Female; Humans; Middle Aged; Pregnancy; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology | 2003 |
Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.
Topics: Adult; Aggression; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Quetiapine Fumarate; Risperidone; Schizophrenia | 2003 |
Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea.
Topics: Adult; Amenorrhea; Analysis of Variance; Antipsychotic Agents; Dibenzothiazepines; Female; Haloperidol; Humans; Prolactin; Quetiapine Fumarate; Recovery of Function; Risperidone; Schizophrenia; Time Factors | 2003 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Schizophrenia, VI: Treatments.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Perphenazine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2003 |
Racial disparity in the use of atypical antipsychotic medications among veterans.
Topics: Antipsychotic Agents; Benzodiazepines; Black or African American; Clozapine; Dibenzothiazepines; Drug Prescriptions; Ethnicity; Hispanic or Latino; Humans; Multivariate Analysis; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; United States; Veterans; White People | 2003 |
Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Schizophrenia; Triglycerides; Weight Gain | 2003 |
Similarities and differences among antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2003 |
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.
Topics: Adult; Alleles; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Minisatellite Repeats; Nerve Tissue Proteins; Olanzapine; Polymorphism, Genetic; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia | 2004 |
Switching to quetiapine in patients with acute mania who were intolerant to risperidone.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2004 |
Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.
Topics: Antipsychotic Agents; Benzodiazepines; Calibration; Chromatography, High Pressure Liquid; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Reference Standards; Risperidone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2004 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Catalepsy; Chlorpromazine; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Haloperidol; Hyperkinesis; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Piperazines; Pyridines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2004 |
Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Hospitals, State; Humans; Length of Stay; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2004 |
Use of polypharmacotherapy in pregnancy: a prospective outcome in a case.
Topics: Adult; Antipsychotic Agents; Apgar Score; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quetiapine Fumarate; Risperidone; Schizophrenia | 2004 |
Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Hyperprolactinemia; International Classification of Diseases; Male; Observation; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Weight Gain | 2004 |
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome | 2004 |
A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Female; Humans; Incidence; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2004 |
Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothiazepines; Dopamine Agonists; Female; Humans; Intubation; Male; MEDLINE; Mental Disorders; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Treatment Outcome | 2004 |
Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Female; Humans; Incidence; Male; Managed Care Programs; Olanzapine; Patient Selection; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2004 |
Effects of typical and atypical antipsychotic drugs on maternal behavior in postpartum female rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Female; Haloperidol; Maternal Behavior; Postpartum Period; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Risperidone | 2004 |
Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate.
Topics: Adolescent; Adult; Age Factors; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survival Analysis; Time Factors; Treatment Outcome; Valproic Acid | 2004 |
The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzazepines; Benzodiazepines; Carbon Radioisotopes; Clozapine; Corpus Striatum; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Diabetic Ketoacidosis; Dibenzothiazepines; Hospitalization; Humans; Incidence; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; United States | 2004 |
Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Case-Control Studies; Clozapine; Demography; Diabetes Mellitus; Dibenzothiazepines; Female; Humans; Hypoglycemic Agents; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sex Factors | 2004 |
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Databases, Factual; Diabetes Mellitus; Dibenzothiazepines; Drug Prescriptions; Female; Humans; Incidence; Insurance Claim Reporting; Male; Middle Aged; Multivariate Analysis; Olanzapine; Outpatients; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; Thioridazine; Time Factors; United States | 2005 |
Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Auditory Perception; Benzodiazepines; Clozapine; Conditioning, Psychological; Dibenzothiazepines; Evoked Potentials, Auditory; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Reaction Time; Reflex, Startle; Risperidone; Schizophrenia | 2004 |
Prolactin elevation with ziprasidone.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Comorbidity; Depression, Postpartum; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Cognition; Dibenzothiazepines; Dose-Response Relationship, Drug; Histamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2004 |
On the simulation of the time-course of dopamine D2 receptor occupancy from the pharmacokinetics of antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Brain; Dibenzothiazepines; Dose-Response Relationship, Drug; Half-Life; Humans; Metabolic Clearance Rate; Models, Statistical; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone | 2005 |
[Management of the atypical antipsychotic olanzapine in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State hospital].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Treatment Outcome | 2004 |
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride | 2004 |
Priapism.
Topics: Adult; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Priapism; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Trazodone | 2004 |
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amenorrhea; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Dibenzothiazepines; Drug Tolerance; Female; Galactorrhea; Gynecomastia; Humans; Male; Observation; Olanzapine; Outcome Assessment, Health Care; Quetiapine Fumarate; Risperidone; Schizophrenia | 2005 |
Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Costs and Cost Analysis; Dibenzothiazepines; Drug Costs; Female; Humans; Inpatients; Male; Mental Health Services; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2004 |
Comparison of clozapine use in Maryland and in Victoria, Australia.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Australia; Benzodiazepines; Catchment Area, Health; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Maryland; Medical Records; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2005 |
Hypokalemia from risperidone and quetiapine overdose.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Drug Overdose; Humans; Hypokalemia; Male; Quetiapine Fumarate; Risperidone | 2005 |
Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Long-Term Care; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2005 |
Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; California; Case-Control Studies; Clozapine; Databases, Factual; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Medicaid; Middle Aged; Odds Ratio; Olanzapine; Quetiapine Fumarate; Risk Assessment; Risperidone; Schizophrenia; Time Factors | 2005 |
Antipsychotic drug-induced weight gain: development of an animal model.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Constitution; Body Weight; Dibenzothiazepines; Eating; Male; Mice; Mice, Inbred C57BL; Models, Animal; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Utilization; Female; Health Care Costs; Humans; Male; Mental Health Services; Multivariate Analysis; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone | 2005 |
Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.
Topics: Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2005 |
FDA warns antipsychotic drugs may be risky for elderly.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dementia; Dibenzothiazepines; Drug Approval; Drug Labeling; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2005 |
Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Incidence; Insurance Coverage; Male; Mental Disorders; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Sex Factors; United States | 2005 |
Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Temperature; Child; Dibenzothiazepines; Electroconvulsive Therapy; Female; Humans; Impulsive Behavior; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid; Violence | 2005 |
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Thiazoles | 2005 |
The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.
Topics: Animals; Antipsychotic Agents; Dibenzothiazepines; Glucose; Insulin; Islets of Langerhans; Male; Organ Culture Techniques; Piperazines; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Thiazoles | 2005 |
Antipsychotic use in the elderly: shifting trends and increasing costs.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Drug Costs; Humans; Mental Disorders; Olanzapine; Ontario; Population Surveillance; Quetiapine Fumarate; Risperidone | 2005 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Olanzapine; Propranolol; Quetiapine Fumarate; Risperidone; Testosterone; Trazodone; Treatment Outcome; Valproic Acid | 2005 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Probability; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risk Assessment; Risperidone; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Treatment Outcome | 2005 |
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Data Interpretation, Statistical; Dementia; Dibenzothiazepines; England; Family Practice; Female; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Olanzapine; Product Surveillance, Postmarketing; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Stroke; Survival Analysis; Time Factors; Treatment Outcome | 2005 |
Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
Topics: Adult; Anti-Obesity Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Child, Preschool; Clozapine; Dibenzothiazepines; Female; Fructose; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Taiwan; Topiramate; Weight Gain | 2005 |
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cohort Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Thiazoles | 2005 |
Thyroid dysfunction during treatment with atypical antipsychotics.
Topics: Antipsychotic Agents; Dibenzothiazepines; Double-Blind Method; Humans; Hyperthyroidism; Hypothyroidism; Placebos; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thyroid Function Tests; Thyroid Hormones | 2005 |
The CATIE schizophrenia effectiveness trial.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Drug Tolerance; Humans; Olanzapine; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2005 |
Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.
Topics: Animals; Antipsychotic Agents; Cocaine; Dibenzothiazepines; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Eating; Fat Emulsions, Intravenous; Female; Hyperkinesis; Male; Motor Activity; Piperazines; Quetiapine Fumarate; Rats; Risperidone; Thiazoles | 2006 |
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Female; Humans; Interview, Psychological; Male; Middle Aged; Olanzapine; Psychometrics; Psychotic Disorders; Quetiapine Fumarate; Reproducibility of Results; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2006 |
Elevated prolactin levels in male youths treated with risperidone and quetiapine.
Topics: Adolescent; Antipsychotic Agents; Child; Cross-Sectional Studies; Dibenzothiazepines; Drug Therapy, Combination; Humans; Hyperprolactinemia; Male; Quetiapine Fumarate; Residential Treatment; Risperidone | 2005 |
Interpreting the results of the CATIE study.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; National Institute of Mental Health (U.S.); Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; United States | 2006 |
Interpreting the results of the CATIE study.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Interpreting the results of the CATIE study.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Antipsychotic drugs and schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2006 |
Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Iowa; Male; Mathematical Computing; Medicaid; Middle Aged; Models, Statistical; Olanzapine; Product Surveillance, Postmarketing; Psychotic Disorders; Quetiapine Fumarate; Regression Analysis; Risk Factors; Risperidone; Statistics as Topic | 2006 |
Diabetes associated with atypical antipsychotic treatment may be severe but reversible: case report.
Topics: Adult; Antipsychotic Agents; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index | 2005 |
[Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics].
Topics: Antipsychotic Agents; Benzodiazepines; Carbohydrate Metabolism; Case-Control Studies; Clozapine; Dibenzothiazepines; Female; Ghrelin; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Olanzapine; Overweight; Peptide Hormones; Quetiapine Fumarate; Resistin; Risperidone; Tumor Necrosis Factor-alpha; Weight Gain | 2005 |
Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.
Topics: Animals; Antipsychotic Agents; Cell Survival; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression; Haloperidol; PC12 Cells; Quetiapine Fumarate; Rats; Receptor, Nerve Growth Factor; Risperidone; RNA, Messenger; Time Factors | 2006 |
Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
Topics: Antipsychotic Agents; Benzodiazepines; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Dibenzothiazepines; Drug Costs; Haloperidol; Health Care Costs; Humans; Models, Econometric; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thailand; Thiazoles; Treatment Outcome | 2005 |
Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Costs; Drug Prescriptions; Drug Utilization Review; Episode of Care; Follow-Up Studies; Humans; Insurance Claim Review; International Classification of Diseases; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2006 |
Practical treatment information for schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Dibenzothiazepines; Female; Humans; Male; Multicenter Studies as Topic; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Male; Mice; Mice, Inbred C57BL; Olanzapine; Phosphorylation; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serine; Thiazoles; Time Factors | 2007 |
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amenorrhea; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Olanzapine; Piperazines; Pituitary Neoplasms; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; United States; United States Food and Drug Administration | 2006 |
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Outpatients; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index; Sexual Dysfunction, Physiological | 2006 |
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Dibenzothiazepines; Female; Humans; Lipids; Male; Mental Disorders; Nursing Homes; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Weight Gain | 2006 |
Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
Topics: Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Humans; Leptin; Lipids; Lipoproteins; Olanzapine; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2006 |
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Chlorpromazine; Clozapine; Cyclosporins; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Flow Cytometry; Fluorescent Dyes; Haloperidol; Isoxazoles; Kidney; Liver; LLC-PK1 Cells; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rhodamine 123; Risperidone; Swine; Transfection | 2006 |
Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Immunoenzyme Techniques; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sex Factors | 2005 |
Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Humans; Male; Mental Disorders; Middle Aged; New Zealand; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2006 |
Quetiapine and citalopram: aetiological significances in serotonin syndrome.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Treatment Outcome | 2006 |
A model of anticholinergic activity of atypical antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Binding Sites; Clozapine; Cognition Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Cholinergic; Risperidone; Schizophrenia; Thiazoles | 2006 |
Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Regression Analysis; Risk Factors; Risperidone; Schizophrenia; United States; Veterans | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbamazepine; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Triazines; Valproic Acid | 2007 |
Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Drug Prescriptions; Female; Humans; International Classification of Diseases; Male; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Time Factors | 2006 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Recurrence; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2006 |
No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs.
Topics: Adipose Tissue; Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Bone Density; Dibenzothiazepines; Dietary Fats; Drug Administration Schedule; Eating; Energy Intake; Female; Lipids; Mice; Mice, Inbred C57BL; Olanzapine; Quetiapine Fumarate; Risperidone; Weight Gain | 2007 |
Alteration in serum neural cell adhesion molecule in patients of schizophrenia.
Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Chronic Disease; Dibenzothiazepines; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Molecular Weight; Neural Cell Adhesion Molecules; Olanzapine; Protein Isoforms; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2007 |
Atypical antipsychotic agents ineffective for AD.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Psychomotor Agitation; Quetiapine Fumarate; Risperidone | 2007 |
The art (and blood sport) of psychopharmacology research: who has a dog in the fight?
Topics: Antipsychotic Agents; Conflict of Interest; Dibenzothiazepines; Drug Industry; Humans; Quetiapine Fumarate; Research Support as Topic; Risperidone; Treatment Outcome | 2007 |
A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
Topics: Antipsychotic Agents; Data Interpretation, Statistical; Dibenzothiazepines; Double-Blind Method; Humans; Placebos; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reproducibility of Results; Risperidone; Schizophrenia | 2007 |
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.
Topics: AMP-Activated Protein Kinase Kinases; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Hypothalamus; Olanzapine; Protein Kinases; Quetiapine Fumarate; Risperidone; Schizophrenia; Weight Gain | 2007 |
Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy; Female; Hospitalization; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles | 2007 |
The outpatient use of atypical antipsychotics with Alzheimer's disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Data Interpretation, Statistical; Dibenzothiazepines; Dopamine Antagonists; Double-Blind Method; Follow-Up Studies; Humans; Multicenter Studies as Topic; Olanzapine; Outpatients; Placebos; Quetiapine Fumarate; Risk Assessment; Risperidone; Serotonin Antagonists; Time Factors; Treatment Outcome | 2007 |
Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clonazepam; Dibenzothiazepines; Female; GABA Modulators; Gonadal Steroid Hormones; Humans; Masturbation; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Sexual Dysfunctions, Psychological; Valproic Acid | 2007 |
[Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Mental Disorders; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Survival Analysis; Treatment Outcome | 2007 |
Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
Topics: Animals; Antipsychotic Agents; Attention; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Haloperidol; Impulsive Behavior; Male; Olanzapine; Phencyclidine; Quetiapine Fumarate; Rats; Rats, Wistar; Reaction Time; Risperidone; Schizophrenia | 2007 |
Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Humans; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Violence | 2007 |
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; China; Cost of Illness; Cost-Benefit Analysis; Databases, Factual; Delayed-Action Preparations; Dibenzothiazepines; Female; Health Care Costs; Hong Kong; Hospitalization; Humans; Male; Medical Records; Middle Aged; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; Substance-Related Disorders; Sulpiride | 2007 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles | 2008 |
Effect of antipsychotic medication use on memory in patients with Alzheimer's disease: Assessing the potential risk for accelerated recent autobiographical memory loss.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Autobiographies as Topic; Benzodiazepines; Dibenzothiazepines; Drug Monitoring; Female; Geriatric Assessment; Haloperidol; Humans; Male; Memory; Mental Status Schedule; Neuropsychological Tests; Nursing Assessment; Olanzapine; Pilot Projects; Quetiapine Fumarate; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2007 |
Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Clozapine; Cohort Studies; Dibenzothiazepines; Drug Utilization; Female; Humans; Male; New Zealand; Olanzapine; Quetiapine Fumarate; Risperidone | 2007 |
Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Child; Child, Preschool; Dibenzothiazepines; Female; Humans; Length of Stay; Male; Mental Disorders; Olanzapine; Outcome and Process Assessment, Health Care; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone; Weight Gain | 2007 |
Early use of clozapine for poorly responding first-episode psychosis.
Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2007 |
Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Dementia; Dibenzothiazepines; Evidence-Based Medicine; Humans; Olanzapine; Psychomotor Agitation; Quetiapine Fumarate; Retrospective Studies; Risperidone; Treatment Outcome | 2007 |
Risperidone- and quetiapine-induced cholestasis.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antipsychotic Agents; Aspartate Aminotransferases; Cholestasis; Dibenzothiazepines; Humans; Male; Quetiapine Fumarate; Risperidone; Schizophrenia | 2007 |
Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports.
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Quetiapine Fumarate; Risperidone; Serotonin Syndrome | 2007 |
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Fetal Blood; Haloperidol; Humans; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Maternal-Fetal Exchange; Olanzapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2007 |
Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Metabolic Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Triglycerides; Waist-Hip Ratio | 2007 |
Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Corpus Striatum; Dibenzothiazepines; Dose-Response Relationship, Drug; Electroencephalography; Female; Hippocampus; Injections, Intraperitoneal; Male; Motor Activity; Movement; Olanzapine; Piperazines; Prefrontal Cortex; Quetiapine Fumarate; Rats; Rats, Inbred F344; Reticular Formation; Risperidone; Thiazoles; Time Factors | 2007 |
Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Follow-Up Studies; Haloperidol; Humans; Male; Medicaid; Middle Aged; Olanzapine; Patient Compliance; Phenothiazines; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2007 |
Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Dementia, Vascular; Dibenzothiazepines; Female; Haloperidol; Humans; Kaplan-Meier Estimate; Male; Medicare Part A; Multivariate Analysis; Olanzapine; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans | 2007 |
Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electroencephalography; Humans; Male; Middle Aged; Polysomnography; Quetiapine Fumarate; Reproducibility of Results; Risperidone; Sample Size; Schizophrenia; Sleep; Sleep, REM | 2007 |
Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Clozapine; Databases, Factual; Dementia; Dibenzothiazepines; Drug Utilization Review; Health Services for the Aged; Humans; Olanzapine; Pharmaceutical Services; Piperazines; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Stroke; Thiazoles; Treatment Outcome | 2007 |
The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain.
Topics: Administration, Oral; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Delayed-Action Preparations; Dibenzothiazepines; Drug Administration Schedule; Female; Follow-Up Studies; Health Care Surveys; Humans; Longitudinal Studies; Male; Olanzapine; Outcome Assessment, Health Care; Patient Dropouts; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Spain; Survival Analysis; Time Factors; Treatment Outcome | 2008 |
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome | 2007 |
Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Intellectual Disability; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Self-Injurious Behavior; Treatment Outcome | 2008 |
Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics?
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Dystonia; Humans; Male; Middle Aged; Neck Muscles; Olanzapine; Parkinsonian Disorders; Quetiapine Fumarate; Risperidone | 2008 |
Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Anxiety; Benzodiazepines; Cross-Sectional Studies; Dementia; Dibenzothiazepines; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Residence Characteristics; Risperidone; Schizophrenia; Serotonin Antagonists; United States | 2008 |
Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Medical Records; Middle Aged; Olanzapine; Patient Admission; Polypharmacy; Practice Patterns, Physicians'; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Scotland; Sulpiride | 2008 |
Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Mental Health Services; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; United States | 2008 |
[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
Topics: Adult; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Erectile Dysfunction; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hungary; International Cooperation; Libido; Male; Menstruation Disturbances; Middle Aged; Olanzapine; Outpatients; Patient Admission; Patient Compliance; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index | 2007 |
Lessons to be learned from CATIE and CUtLASS.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Health Care Costs; Humans; Informed Consent; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2008 |
Did CATIE influence antipsychotic use?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy; Haloperidol; Humans; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2008 |
Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Inventory; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2008 |
Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
Topics: Adult; Antipsychotic Agents; Arousal; Dibenzothiazepines; Erectile Dysfunction; Female; Humans; Libido; Male; Middle Aged; Orgasm; Prolactin; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Testosterone | 2008 |
[Edema related to treatment with olanzapine].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Therapy, Combination; Edema; Female; Humans; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2009 |
Revised Korean medication algorithm for bipolar disorder.
Topics: Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Health Personnel; Humans; Korea; Olanzapine; Psychiatry; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Valproic Acid | 2009 |
Parkinsonism and akathisia with quetiapine: three case reports.
Topics: Adolescent; Antipsychotic Agents; Dibenzothiazepines; Female; Hallucinations; Humans; Parkinsonian Disorders; Psychomotor Agitation; Quetiapine Fumarate; Risperidone | 2008 |
Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.
Topics: Adiponectin; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia | 2008 |
Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.
Topics: Adenosine Triphosphate; Antipsychotic Agents; Cell Line; Cell Survival; Dibenzothiazepines; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isoxazoles; Monocytes; Neurons; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Risperidone; Thiazoles | 2010 |
QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Dibenzothiazepines; Electrocardiography; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2008 |
Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; California; Databases, Factual; Decision Making; Dibenzothiazepines; Female; Humans; Male; Medicaid; Middle Aged; Olanzapine; Patient Selection; Psychotic Disorders; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; United States; Young Adult | 2009 |
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Cost of Illness; Dibenzothiazepines; Female; Follow-Up Studies; Haloperidol; Humans; Kaplan-Meier Estimate; Long-Term Care; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Psychopharmacology news.
Topics: Antipsychotic Agents; Bipolar Disorder; Congresses as Topic; Delayed-Action Preparations; Dibenzothiazepines; Drug Approval; Humans; Quetiapine Fumarate; Risperidone; Schizophrenia; United States; United States Food and Drug Administration | 2009 |
Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Medication adherence for children and adolescents with first-episode psychosis following hospitalization.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Cohort Studies; Dibenzothiazepines; Epidemiologic Studies; Female; Humans; Length of Stay; Male; Olanzapine; Patient Compliance; Patient Discharge; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Treatment Outcome; United States | 2009 |
Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia, Paranoid | 2010 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |
Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Hypoglycemia; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2009 |
Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population.
Topics: Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dibenzothiazepines; Dyslipidemias; Female; Haloperidol; Humans; Hypertriglyceridemia; Male; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risk Assessment; Risperidone; Time Factors; United States; United States Department of Veterans Affairs | 2009 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Self-medication, bipolar disorders, and stimulant dependence.
Topics: Affect; Antipsychotic Agents; Bipolar Disorder; Central Nervous System Stimulants; Comorbidity; Dibenzothiazepines; Humans; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Self Medication; Substance-Related Disorders | 2009 |
Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Withholding Treatment | 2009 |
[Antipsychotic treatment of dementia after publication of new risks].
Topics: Adverse Drug Reaction Reporting Systems; Aged; Alzheimer Disease; Antipsychotic Agents; Cerebral Infarction; Dibenzothiazepines; Drug Therapy, Combination; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Germany; Humans; Male; Practice Patterns, Physicians'; Publication Bias; Quetiapine Fumarate; Risk; Risperidone | 2010 |
[Complex therapy of schizophrenia].
Topics: Adolescent; Adult; Antipsychotic Agents; Art Therapy; Benzodiazepines; Clinical Trials as Topic; Clozapine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dance Therapy; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Music Therapy; Occupational Therapy; Olanzapine; Psychotherapy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Suicide; Treatment Outcome; Young Adult | 2009 |
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Child; Child, Preschool; Cohort Studies; Dibenzothiazepines; Female; Humans; Lipid Metabolism; Lipids; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Weight Gain | 2009 |
Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Insulin; Lithium Carbonate; Male; Obesity; Olanzapine; Overweight; Prospective Studies; Quetiapine Fumarate; Risperidone; Triglycerides; Valproic Acid; Weight Gain; Young Adult | 2010 |
Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Male; Medical Audit; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk Factors; Risperidone | 2009 |
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study.
Topics: Adult; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Female; Finland; Haloperidol; Humans; Male; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Suicide; Survival Rate | 2010 |
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Neuroleptic Malignant Syndrome; Nursing Research; Olanzapine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Quinolones; Receptor, Serotonin, 5-HT2A; Risperidone; Thiazoles | 2011 |
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Drug Utilization; Evidence-Based Medicine; Female; Humans; Infant; Insurance Claim Review; Male; Medicaid; Mental Disorders; Off-Label Use; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2010 |
An examination of the relative contribution of saturation and selective attention to memory deficits in patients with recent-onset schizophrenia and their unaffected parents.
Topics: Age of Onset; Antipsychotic Agents; Attention; Clozapine; Dibenzothiazepines; Female; Humans; Male; Memory Disorders; Memory, Short-Term; Neuropsychological Tests; Parents; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Young Adult | 2010 |
Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Topics: Adult; Age Distribution; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Databases, Factual; Dibenzothiazepines; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Female; Humans; Kaplan-Meier Estimate; Male; Mental Disorders; Middle Aged; Olanzapine; Patient Compliance; Quebec; Quetiapine Fumarate; Registries; Retrospective Studies; Risperidone; Sex Distribution; Young Adult | 2010 |
Second-generation antipsychotics cause weight gain in youths.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Dibenzothiazepines; Humans; Olanzapine; Overweight; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Weight Gain | 2010 |
The dose-dependent effect of chronic administration of haloperidol, risperidone, and quetiapine on sexual behavior in the male rat.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Dibenzothiazepines; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin Antagonists; Sexual Behavior, Animal; Sexual Dysfunction, Physiological; Statistics as Topic; Time Factors | 2011 |
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Topics: Adult; Alleles; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cytochrome P-450 CYP2D6; Dibenzothiazepines; Drug Therapy, Combination; Fluphenazine; Genetic Carrier Screening; Genotype; Haloperidol; Humans; Lithium Carbonate; Male; Neuroleptic Malignant Syndrome; Perazine; Polymorphism, Genetic; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Recurrence; Risperidone | 2010 |
Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Ethnicity; Female; Humans; Lithium Carbonate; Male; Observation; Olanzapine; Personality Disorders; Prospective Studies; Quetiapine Fumarate; Remission Induction; Risperidone; Severity of Illness Index; Substance-Related Disorders; Valproic Acid | 2010 |
Recommendations on the drug treatment of psychosis in Parkinson's disease.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2010 |
Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Biomarkers; Bipolar Disorder; Body Mass Index; Child; Cholesterol, LDL; Chromatography, High Pressure Liquid; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Obesity; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thyroxine; Treatment Outcome; Weight Gain | 2010 |
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
Topics: Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Cholinesterase Inhibitors; Dementia; Dibenzothiazepines; Drug Prescriptions; Female; Hospitals, University; Humans; Italy; Male; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone | 2010 |
Trends in antipsychotic prescribing practices in an urban community mental health clinic.
Topics: Administration, Oral; Anticonvulsants; Antipsychotic Agents; Case Management; Community Mental Health Centers; Cross-Sectional Studies; Delayed-Action Preparations; Dibenzothiazepines; Drug Utilization; Humans; Hypnotics and Sedatives; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Urban Population; Victoria | 2010 |
Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Comorbidity; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Sex Factors; Veterans | 2010 |
[Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Topics: Adult; Antioxidants; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Glutathione Peroxidase; Haloperidol; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Olanzapine; Oxidative Stress; Quetiapine Fumarate; Risperidone; Schizophrenia; Superoxide Dismutase | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Phospholipases A2; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; Treatment Outcome; Young Adult | 2011 |
A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
Topics: Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Female; Humans; Inpatients; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain | 2011 |
Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Topics: Alcoholism; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Central Nervous System Depressants; Comorbidity; Dibenzothiazepines; Ethanol; Humans; Hyperkinesis; Male; Motor Activity; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles; Time Factors | 2011 |
Some effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaques.
Topics: Age Factors; Animals; Antipsychotic Agents; Body Weight; Bone and Bones; Bone Density; Child; Child, Preschool; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Macaca nemestrina; Male; Models, Animal; Prolactin; Quetiapine Fumarate; Random Allocation; Risperidone; Thyroid Hormones | 2010 |
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Dibenzothiazepines; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Interactions; Hallucinogens; Haloperidol; Humans; Male; Models, Animal; Motor Activity; Phencyclidine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Reflex, Startle; Risperidone | 2011 |
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drinking Water; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Haloperidol; Isoxazoles; Linoleoyl-CoA Desaturase; Liver; Male; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rats; Rats, Long-Evans; Risperidone; RNA, Messenger | 2011 |
[Delusion of parasitosis due to Wegener's granulomatosis].
Topics: Antipsychotic Agents; Delusions; Dibenzothiazepines; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Middle Aged; Nasal Cavity; Parasitic Diseases; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2011 |
Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.
Topics: Adiponectin; Adolescent; Adolescent Development; Antipsychotic Agents; Basal Metabolism; Benzodiazepines; Biomarkers; Body Composition; Child; Cohort Studies; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone; Waist Circumference; Weight Gain | 2011 |
A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Diabetes Mellitus, Type 2; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Glycated Hemoglobin; Hemoglobins; Humans; Hypoglycemic Agents; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; United States | 2011 |
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult | 2011 |
False positive urine drug screening for tricyclic antidepressants in patients taking quetiapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Dibenzothiazepines; False Positive Reactions; Female; Humans; Male; Quetiapine Fumarate; Risperidone; Schizophrenia | 2011 |
Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Child; Clozapine; Cohort Studies; Dibenzothiazepines; Female; Humans; Incidence; Male; Middle Aged; New Zealand; Nocturnal Enuresis; Olanzapine; Product Surveillance, Postmarketing; Quetiapine Fumarate; Risperidone; Urban Population; Young Adult | 2011 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hallucinations; Haloperidol; Humans; Hungary; Male; Marijuana Abuse; Olanzapine; Paranoid Disorders; Piperazines; Psychomotor Performance; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology | 2011 |
Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Topics: Antipsychotic Agents; Catecholamines; Diagnosis, Differential; Dibenzothiazepines; Dopamine; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Risperidone; Serotonin; Serotonin Syndrome | 2011 |
Switching antipsychotic medications: not enough, too often, or just right?
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia | 2011 |
[Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Butyrophenones; Clozapine; Delayed-Action Preparations; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Patient Dropouts; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Young Adult | 2011 |
Adjunctive antipsychotics for major depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Approval; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration | 2011 |
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.
Topics: Academic Medical Centers; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Weight Gain | 2011 |
Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors | 2011 |
The genotoxic potentials of some atypical antipsychotic drugs on human lymphocytes.
Topics: Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Cell Survival; Dibenzothiazepines; DNA Damage; Humans; Lymphocytes; Micronucleus Tests; Mutagenicity Tests; Mutagens; Olanzapine; Quetiapine Fumarate; Risperidone | 2012 |
[Sexual disturbances during the treatment with neuroleptics in patients with schizophrenia and schizophrenia spectrum disorders].
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Young Adult | 2011 |
Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Attention; Bipolar Disorder; British Columbia; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Executive Function; Female; Humans; Longitudinal Studies; Male; Memory, Short-Term; Neurotoxicity Syndromes; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Verbal Learning; Young Adult | 2012 |
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome | 2011 |
Risk of mortality among individual antipsychotics in patients with dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Time Factors; Valproic Acid | 2012 |
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride | 2012 |
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chi-Square Distribution; Clozapine; Dibenzothiazepines; Humans; Missouri; Olanzapine; Piperazines; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Antipsychotics and mortality in Parkinsonism.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cohort Studies; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Ontario; Parkinsonian Disorders; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone | 2012 |
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Dibenzothiazepines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Pneumonia; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Taiwan | 2013 |
Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
Topics: Accidental Falls; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Female; Follow-Up Studies; Fractures, Bone; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Propensity Score; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2012 |
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cause of Death; Comorbidity; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Epidemiologic Methods; Female; Haloperidol; Humans; Male; Medical Assistance; Mortality; Nursing Homes; Quetiapine Fumarate; Risperidone; United States | 2012 |
Atypical antipsychotic medications to control symptoms of delirium in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Delirium; Dibenzothiazepines; Female; Hospitals, Pediatric; Humans; Infant; Los Angeles; Male; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Severity of Illness Index; Treatment Outcome | 2012 |
Reduced arterial compliance in patients with psychiatric diagnoses.
Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; Blood Pressure; Compliance; Dibenzothiazepines; Femoral Artery; Humans; Male; Mental Disorders; Middle Aged; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2012 |
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Databases, Factual; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Publication Bias; Pyrimidines; Quetiapine Fumarate; Quinolones; Risperidone; United States; United States Food and Drug Administration | 2012 |
Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Valproic Acid | 2012 |
Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Interpretation, Statistical; Dibenzothiazepines; Humans; Olanzapine; Patient Dropouts; Piperazines; Quetiapine Fumarate; Quinolones; Review Literature as Topic; Risperidone; Schizophrenia; Sulpiride | 2012 |
Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hospital Administration; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Selection Bias; Survival Analysis; Time Factors; Treatment Outcome | 2012 |
Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Down-Regulation; Female; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Up-Regulation; Young Adult | 2012 |
Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Auditory Cortex; Benzodiazepines; Dibenzothiazepines; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Reaction Time; Receptor, Adenosine A2A; Risperidone; Schizophrenia; Sensory Gating; Up-Regulation | 2012 |
Subtypes of antipsychotics and suicidal behavior in bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Suicidal Ideation; Suicide; Suicide Prevention; Suicide, Attempted; Veterans | 2012 |
Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Europe; Female; Humans; Logistic Models; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2012 |
Neuroleptics: bedwetting.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Nocturnal Enuresis; Olanzapine; Quetiapine Fumarate; Risperidone | 2012 |
Atypical antipsychotic medication: a nightmarish problem!
Topics: Antipsychotic Agents; Dibenzothiazepines; Dreams; Female; Humans; Male; Middle Aged; Quetiapine Fumarate; Risperidone; Schizophrenia | 2012 |
Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Vessels; Brain; Cohort Studies; Dibenzothiazepines; Emergency Medical Services; Female; Hospitalization; Housing; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Residence Characteristics; Retrospective Studies; Risk; Risperidone | 2012 |
Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Incidence; Male; Olanzapine; Parkinson Disease, Secondary; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Sex Factors | 2012 |
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Olanzapine; Predictive Value of Tests; Quetiapine Fumarate; Regression Analysis; Risperidone | 2013 |
Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances.
Topics: Adult; Ambulances; Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Victoria | 2013 |
Association between second-generation antipsychotics and changes in body mass index in adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Confidence Intervals; Dibenzothiazepines; Female; Humans; Male; Medical Audit; Olanzapine; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; United States; Weight Gain | 2013 |
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
Topics: Adolescent; Adult; Anisotropy; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Brain Mapping; Case-Control Studies; Dibenzothiazepines; Diffusion Tensor Imaging; Female; Frontal Lobe; Gyrus Cinguli; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Young Adult | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.
Topics: Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Confidence Intervals; Cross-Over Studies; Dibenzothiazepines; Humans; Middle Aged; Odds Ratio; Olanzapine; Quetiapine Fumarate; Risk; Risperidone; Stroke | 2013 |
Comparative safety of antipsychotics: another look at the risk of diabetes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; Young Adult | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Canada; Dementia; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Phenothiazines; Proportional Hazards Models; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2013 |
German insurer finds a third of people over 65 take five or more drugs a day.
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Dibenzothiazepines; Drug Costs; Electronic Health Records; Female; Germany; Humans; Insurance Carriers; Insurance, Health; Male; Polypharmacy; Prescription Drugs; Quetiapine Fumarate; Risperidone; Tiapride Hydrochloride; Young Adult | 2013 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Carbamazepine; Causality; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Galactorrhea; Humans; Lamotrigine; Logistic Models; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Switzerland; Triazines; Valproic Acid; Weight Gain; Young Adult | 2013 |
Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics.
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cholesterol; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Triglycerides; Victoria | 2014 |
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2013 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
Predictors of response to second generation antipsychotics in drug naïve patients with schizophrenia: a 1 year follow-up study in Shanghai.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; China; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2014 |
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Topics: Academic Medical Centers; Adult; Ambulatory Care Facilities; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; California; Dibenzothiazepines; Drug Therapy; Female; Humans; Lamotrigine; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Referral and Consultation; Risperidone; Triazines | 2014 |
Risperidone and quetiapine-related arthralgia.
Topics: Adult; Antipsychotic Agents; Arthralgia; Dibenzothiazepines; Humans; Male; Quetiapine Fumarate; Risperidone | 2014 |
Do prior authorization policies discourage first-line antipsychotic use in patients newly discharged from a hospitalization for schizophrenia in Saskatchewan?
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases, Factual; Dibenzothiazepines; Female; Humans; Insurance, Health, Reimbursement; Male; Olanzapine; Patient Discharge; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone; Saskatchewan; Schizophrenia | 2014 |
Quetiapine treatment in youth is associated with decreased insulin secretion.
Topics: Adolescent; Animals; Antipsychotic Agents; Blood Glucose; Body Mass Index; Child; Cross-Sectional Studies; Dibenzothiazepines; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mental Disorders; Mice; Mice, Inbred C57BL; Quetiapine Fumarate; Risperidone | 2014 |
Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Topics: Administration, Oral; Adult; Alcoholic Intoxication; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Service, Hospital; Female; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2014 |
Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Cohort Studies; Denmark; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Registries; Risk; Risperidone; Sensitivity and Specificity; Young Adult | 2014 |
Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2014 |
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cause of Death; Creatinine; Dibenzothiazepines; Female; Hospitalization; Humans; Hypotension; Male; Olanzapine; Ontario; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Urinary Retention | 2014 |
Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Emergency Service, Hospital; Female; Hospitalization; Humans; Male; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Taiwan; Treatment Outcome | 2014 |
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Disease Models, Animal; Epilepsy; Haloperidol; Mental Disorders; Olanzapine; Quetiapine Fumarate; Rats; Risperidone; Seizures | 2015 |
Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Dibenzothiazepines; Female; Humans; Male; Mental Disorders; Olanzapine; Prognosis; Prospective Studies; Quetiapine Fumarate; Risk Factors; Risperidone | 2014 |
Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Drug Therapy, Combination; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Middle Aged; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Taiwan | 2015 |
Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Delirium; Female; Half-Life; Haloperidol; Humans; Male; Middle Aged; Neoplasms; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index | 2016 |
Falls and fractures with atypical antipsychotic medication use: a population-based cohort study.
Topics: Accidental Falls; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Female; Fractures, Bone; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2015 |
Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Female; Humans; Male; Middle Aged; Outpatients; Psychomotor Agitation; Quetiapine Fumarate; Retrospective Studies; Risperidone; Severity of Illness Index; Sulpiride; Taiwan; Treatment Outcome | 2015 |
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
Treatment changes among older patients with dementia treated with antipsychotics.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Follow-Up Studies; Humans; Male; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone; United States | 2015 |
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Psychotropic Drugs; Quetiapine Fumarate; Registries; Retrospective Studies; Risk; Risperidone; United States; Veterans | 2015 |
Implications of atypical antipsychotic prescribing in the intensive care unit.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Delirium; Disorders of Excessive Somnolence; Female; Humans; Inappropriate Prescribing; Intensive Care Units; Male; Middle Aged; Olanzapine; Patient Discharge; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survivors; Thiazoles | 2015 |
Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Biomarkers; C-Reactive Protein; Clozapine; Female; Humans; Inflammation; Male; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Risperidone; ROC Curve | 2016 |
[Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Atherosclerosis; Benzodiazepines; Dibenzothiazepines; Electrocardiography; Female; Humans; Lipid Metabolism; Lipoproteins, VLDL; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia, Paranoid; Weight Gain; Young Adult | 2015 |
Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Body Mass Index; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Observational Studies as Topic; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Time Factors; Weight Gain; Young Adult | 2015 |
Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cohort Studies; Female; Finland; Follow-Up Studies; Haloperidol; Humans; Male; Prevalence; Quetiapine Fumarate; Registries; Risperidone; Time Factors; Treatment Outcome | 2015 |
Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.
Topics: Adolescent; Adult; Antipsychotic Agents; Asian People; Chi-Square Distribution; China; Chlorpromazine; Clozapine; Cross-Sectional Studies; Female; Genetic Association Studies; Haplotypes; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pharmacogenomic Testing; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Quetiapine Fumarate; Reelin Protein; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2016 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
[Eating disorders in psychiatric patients during treatment with second generation antipsychotics].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Feeding and Eating Disorders; Female; Humans; Male; Obesity; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2015 |
Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Olanzapine; Parkinson Disease, Secondary; Quetiapine Fumarate; Risperidone | 2015 |
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; CD36 Antigens; Cohort Studies; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Humans; Interleukin-10; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2016 |
Risperidone, quetiapine and chlorpromazine may have induced priapism in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Chlorpromazine; Drug Therapy, Combination; Humans; Male; Penis; Priapism; Quetiapine Fumarate; Risperidone; Ultrasonography, Doppler | 2016 |
From the Editor-in-Chief's Desk.
Topics: Bipolar Disorder; Depression; Gynecomastia; Humans; Mental Processes; Quetiapine Fumarate; Reward; Risperidone | 2015 |
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Monitoring; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2016 |
Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chlorpromazine; Critical Illness; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Mortality; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Taiwan; Time Factors; Young Adult | 2016 |
Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.
Topics: Adolescent; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Blood Pressure; Body Mass Index; British Columbia; Child; Child Development Disorders, Pervasive; Child, Preschool; Cholesterol; Cholesterol, HDL; Cohort Studies; Dyslipidemias; Female; Humans; Incidence; Longitudinal Studies; Male; Mental Disorders; Metabolic Syndrome; Mood Disorders; Obesity; Overweight; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Waist Circumference | 2015 |
Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Computer Simulation; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Humans; Injections, Intramuscular; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; State Medicine; United Kingdom | 2015 |
Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.
Topics: Adolescent; Aripiprazole; Arousal; Benzodiazepines; Child; Cohort Studies; Female; Humans; Male; Olanzapine; Patient Outcome Assessment; Psychomotor Agitation; Quetiapine Fumarate; Risperidone; Schizophrenia, Childhood; Schizophrenic Psychology; Wakefulness | 2016 |
Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.
Topics: Antioxidants; Antipsychotic Agents; Benzodiazepines; Biphenyl Compounds; Clozapine; Free Radical Scavengers; Haloperidol; Humans; Models, Biological; Neutrophil Activation; Neutrophils; Olanzapine; Picrates; Piperazines; Quetiapine Fumarate; Reactive Oxygen Species; Risperidone; Tetradecanoylphorbol Acetate; Thiazoles | 2016 |
Post authorization safety study comparing quetiapine to risperidone and olanzapine.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mortality; Netherlands; Olanzapine; Product Surveillance, Postmarketing; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2016 |
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Veins; Young Adult | 2016 |
Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Quebec; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2016 |
Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
Topics: Action Potentials; Animals; Antipsychotic Agents; Atrioventricular Block; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Rate; Heart Ventricles; Isolated Heart Preparation; Potassium; Quetiapine Fumarate; Rabbits; Risk Assessment; Risperidone; Tachycardia, Ventricular; Time Factors; Torsades de Pointes | 2016 |
Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Olanzapine; Primary Health Care; Propensity Score; Quetiapine Fumarate; Risperidone; Schizophrenia; United Kingdom; Young Adult | 2017 |
Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Belgium; Benzodiazepines; Cross-Sectional Studies; Drug Industry; Drug Prescriptions; Drug Utilization Review; Female; Humans; Male; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia | 2017 |
Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Insurance Claim Review; Lurasidone Hydrochloride; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; United States | 2017 |
Atypical Antipsychotics and the Risks of Acute Kidney Injury and Related Outcomes Among Older Adults: A Replication Analysis and an Evaluation of Adapted Confounding Control Strategies.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2017 |
Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Finland; Hip Fractures; Humans; Long-Term Care; Male; Proportional Hazards Models; Quetiapine Fumarate; Risk; Risperidone | 2017 |
Evaluation of the effects of anti-psychotic drugs on the expression of CD68 on the peripheral blood monocytes of Alzheimer patients with psychotic symptoms.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antipsychotic Agents; Case-Control Studies; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Inflammation; Male; Monocytes; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Vitamin B 12 | 2017 |
A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; DNA, Mitochondrial; Female; Genes, Mitochondrial; Genome-Wide Association Study; Humans; Male; Olanzapine; Pharmacogenomic Testing; Pharmacogenomic Variants; Prospective Studies; Quetiapine Fumarate; Risk Factors; Risperidone; Weight Gain; White People | 2017 |
Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
Topics: Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Autonomic Nervous System Diseases; Benzodiazepines; Cross-Sectional Studies; Electrocardiography; Female; Heart Rate; Humans; Japan; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2018 |
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.
Topics: Adolescent; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Neoplasm Proteins; Olanzapine; Pediatrics; Polymorphism, Genetic; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Middle Aged; Norway; Olanzapine; Quetiapine Fumarate; Risperidone; Sex Factors; Young Adult | 2017 |
Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study.
Topics: Adolescent; Antipsychotic Agents; Basal Ganglia Diseases; Child; Cohort Studies; Female; Humans; Male; Manitoba; Movement Disorders; Population Surveillance; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone | 2017 |
Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Partial Agonism; Male; Quetiapine Fumarate; Rats, Wistar; Recognition, Psychology; Risperidone; Tropisetron | 2018 |
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Cohort Studies; Dementia; Female; Germany; Haloperidol; Homes for the Aged; Humans; Institutionalization; Long-Term Care; Male; Middle Aged; Nursing Homes; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone | 2018 |
Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood; Clozapine; Female; Humans; Lipid Peroxidation; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Thiobarbituric Acid Reactive Substances; Young Adult | 2018 |
Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Female; Humans; Male; Metabolic Diseases; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Triglycerides; Young Adult | 2018 |
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Comorbidity; Depressive Disorder, Major; Female; Humans; Incidence; Infant; Male; Mental Disorders; Norway; Olanzapine; Prevalence; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2018 |
Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.
Topics: Adolescent; Alberta; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Cohort Studies; Drug Prescriptions; Female; Follow-Up Studies; Humans; Male; Neurodevelopmental Disorders; Population Surveillance; Quetiapine Fumarate; Risperidone | 2018 |
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
Topics: Administration, Oral; Adult; Bipolar Disorder; Cohort Studies; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; Humans; Injections, Intramuscular; Lithium Carbonate; Male; Middle Aged; Patient Readmission; Perphenazine; Prospective Studies; Psychotropic Drugs; Quetiapine Fumarate; Risk; Risperidone; Treatment Outcome | 2018 |
Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
Topics: Administration, Oral; Adult; Algorithms; Antipsychotic Agents; Clozapine; Commitment of Mentally Ill; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Methotrimeprazine; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2019 |
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes, Gestational; Female; Humans; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles; Young Adult | 2018 |
Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Body Weight; Cohort Studies; Databases, Factual; Female; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Olanzapine; Primary Health Care; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; United Kingdom; Weight Gain | 2018 |
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Autonomic Nervous System; Cross-Sectional Studies; Female; Heart Rate; Humans; Male; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia | 2018 |
Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cerebral Cortex; Clozapine; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Risperidone But Not Quetiapine Treatment Is Associated With Increased Appetite But Not Satiety Hormones in Children During An Oral Glucose Tolerance Test: A Pilot Study.
Topics: Adolescent; Antipsychotic Agents; Appetite; Child; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Peptide Hormones; Pilot Projects; Quetiapine Fumarate; Risperidone; Satiation | 2018 |
Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Cytokines; Female; Gene Expression; Gene Expression Regulation; Humans; Immunity, Innate; Immunologic Factors; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Receptors, Cytokine; Risperidone; Up-Regulation; Young Adult | 2019 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult | 2019 |
Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Desvenlafaxine Succinate; Doxepin; Drug Monitoring; Female; Glucuronosyltransferase; Humans; Male; Middle Aged; Mirtazapine; Nortriptyline; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Smoking; Venlafaxine Hydrochloride | 2019 |
Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; C-Reactive Protein; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; Young Adult | 2020 |
Comparison of the association of risperidone and quetiapine with deteriorating performance in walking and dressing in subjects with Parkinson's disease: a retrospective cohort study using administrative claims data.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Male; Parkinson Disease; Quetiapine Fumarate; Retrospective Studies; Risperidone; Walking | 2019 |
Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Female; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia | 2019 |
Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cohort Studies; Female; Finland; Follow-Up Studies; Health Status; Hospitalization; Humans; Length of Stay; Male; Matched-Pair Analysis; Quetiapine Fumarate; Registries; Risperidone | 2019 |
Psychotropic-Induced Priapism in a Treatment-Refractory Patient: A Case Report.
Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Male; Priapism; Quetiapine Fumarate; Risperidone | 2021 |
Effects of long-term antipsychotics treatment on body weight: A population-based cohort study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Body Weight; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; Weight Gain; Young Adult | 2020 |
In vivo 5-HT
Topics: Adult; Antipsychotic Agents; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Putamen; Quetiapine Fumarate; Quinolines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin; Sulfones; Young Adult | 2020 |
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States | 2020 |
Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Genome-Wide Association Study; Humans; Quetiapine Fumarate; Receptors, Metabotropic Glutamate; Risk Factors; Risperidone; Schizophrenia | 2020 |
Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Databases, Factual; Female; Humans; Incidence; Male; New Zealand; Olanzapine; Parkinson Disease, Secondary; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Time Factors | 2020 |
Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Inpatients; Kaplan-Meier Estimate; Male; Olanzapine; Patient Readmission; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; Young Adult | 2020 |
Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
Topics: Adult; Autism Spectrum Disorder; Cohort Studies; Comorbidity; Female; Humans; Intellectual Disability; Male; Multimorbidity; Pharmacovigilance; Polypharmacy; Psychotropic Drugs; Quetiapine Fumarate; Risperidone; Young Adult | 2020 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Discontinuation of antipsychotics treatment for elderly patients within a specialized behavioural unit: a retrospective review.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Humans; Ontario; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2021 |
Mortality and morbidity following postoperative use of short-term, low-dose quetiapine vs risperidone in patients with diabetes: Analysis using a national inpatient database.
Topics: Antipsychotic Agents; Diabetes Mellitus; Humans; Inpatients; Morbidity; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2020 |
Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Outpatients; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2021 |
Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study.
Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Duration of Therapy; Female; Finland; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report.
Topics: Aged; Antipsychotic Agents; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Patient Compliance; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Treatment Outcome | 2021 |
Infection is associated with elevated serum concentrations of antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Clozapine; Humans; Quetiapine Fumarate; Respiratory Tract Infections; Risperidone | 2021 |
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis.
Topics: Adult; Benzodiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Substance-Related Disorders; Thiazoles | 2021 |
Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Cohort Studies; Humans; Independent Living; Quetiapine Fumarate; Risperidone; Stroke | 2022 |
Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
Topics: Adolescent; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Australia; Benzodiazepines; Child; Child, Preschool; Drug Prescriptions; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Melatonin; Primary Health Care; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2022 |
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
Topics: Antipsychotic Agents; Benzodiazepines; COVID-19; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; SARS-CoV-2 | 2022 |
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles | 2022 |
Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study.
Topics: Acute Kidney Injury; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Denmark; Hospitals; Humans; Incidence; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Longitudinal Studies; Olanzapine; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Risperidone; Weight Gain | 2022 |
The relation between second-generation antipsychotics and laxative use in elderly patients with schizophrenia.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Constipation; Female; Humans; Laxatives; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2022 |
Association Between Sexual Dysfunction and Dose of Atypical Antipsychotics: Essential to Learn the Basics.
Topics: Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2023 |
Incidence of antipsychotic use among community dwellers with and without Parkinson's disease.
Topics: Antipsychotic Agents; Cohort Studies; Humans; Incidence; Parkinson Disease; Quetiapine Fumarate; Risperidone | 2022 |
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Olanzapine; Psychiatry; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone; Valproic Acid | 2022 |
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse.
Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Menopause; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2023 |
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Japan; Lamotrigine; Lithium Carbonate; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
Risk assessment of accidental falls in patients taking trazodone, quetiapine, or risperidone for insomnia: A single-center, case-control study.
Topics: Accidental Falls; Case-Control Studies; Child; Humans; Quetiapine Fumarate; Risk Assessment; Risperidone; Sleep Initiation and Maintenance Disorders; Trazodone | 2022 |
Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Erectile Dysfunction; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Mentally Ill Persons; Olanzapine; Pregnancy; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone | 2023 |
Antipsychotics Induced Reproductive Toxicity by Stimulating Oxidative Stress: A Comparative in Vivo and in Silico Study.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Haloperidol; Male; Quetiapine Fumarate; Rats; Risperidone; Semen | 2023 |
Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.
Topics: Aged; Antipsychotic Agents; Cohort Studies; Emergence Delirium; Female; Haloperidol; Hospital Mortality; Hospitals; Humans; Ischemic Attack, Transient; Male; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2023 |
When the fever will not stop, stop the pills! A case report.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Risperidone | 2023 |